This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence
F5_BEHEMOTH
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2540 |
4. Check minimum number of eventsNone |
2540 |
5. Include endpointsNone |
2540 |
6. Filter based on genotype QC (FinnGen only) |
2540 |
Control definitions (FinnGen only)
- Control exclude
- F5_BEHEMOCHILD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F90-F98
- Name in latin
- Aliae perturbationes modi se gerendi et emotionales usitate in pueritia sive adolescentia incipientes
Similar endpoints
↥List of similar endpoints to
Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence
based on the number of shared cases.
Similar with more cases:
- Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
- Any mental disorder
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2540 | 1533 | 1007 |
| Unadjusted period prevalence (%) | 0.49 | 0.52 | 0.44 |
| Median age at first event (years) | 9.45 | 9.52 | 9.33 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2260
- Matched controls
- 22253
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
490.1
323.0
377
9
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
162.2
323.0
460
35
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
482.0
323.0
406
10
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
13.9
248.1
451
392
N06BA04
ATC
methylphenidate; oral
20.0
236.3
368
214
F98.02
ICD-10 Finland
Non-organic nocturnal and diurnal enuresis
+∞
233.2
221
*
F90.0
ICD-10 Finland
Disturbance of activity and attention
16.8
231.5
386
270
30660
ICD-8 Finland
Special symptoms not elsewhere classified, Enuresis
+∞
224.6
213
*
F98.01
ICD-10 Finland
Non-organic diurnal enuresis
540.0
204.0
201
*
G04BD04
ATC
oxybutynin; oral, transdermal
18.9
179.9
285
169
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
1918.2
178.5
172
*
F98.0
ICD-10 Finland
Nonorganic enuresis
547.2
158.0
156
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.1
136.7
631
1906
F93.89
ICD-10 Finland
Other childhood emotional disorders
102.5
124.7
137
14
XKD00
NOMESCO Finland
Uroflowmetry
6.5
100.2
279
470
30670
ICD-8 Finland
Special symptoms not elsewhere classified, Encopresis
+∞
97.0
93
*
F98.5
ICD-10 Finland
Stuttering [stammering]
173.4
96.4
101
6
N05AH04
ATC
quetiapine; oral
3.3
94.9
583
2136
R32
ICD-10 Finland
Unspecified urinary incontinence
18.4
91.1
144
82
N05AX08
ATC
risperidone; systemic
5.6
87.1
273
531
Z2445
NOMESCO Finland
Psychologist
4.5
87.0
342
851
N06AB03
ATC
fluoxetine; oral
3.7
73.4
359
1079
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.9
68.8
489
1923
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.3
66.7
266
663
ZY010
NOMESCO Finland
Hospital outpatient
3.7
64.8
318
953
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
5.4
64.7
208
412
N05AX12
ATC
aripiprazole; systemic
5.1
64.3
218
459
F98.19
ICD-10 Finland
Non-organic encopres UNS
625.6
62.8
62
*
Z2446
NOMESCO Finland
Social worker
3.3
62.7
362
1226
3076C
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Enuresis[YÖ- JA PÄIVÄKASTELU]
+∞
61.4
59
*
N05AH03
ATC
olanzapine; systemic
4.2
60.4
251
648
F98.10
ICD-10 Finland
Non-organic encapsulation never normal control of intestinal function
+∞
60.3
58
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.2
58.8
342
1162
Z3231
NOMESCO Finland
Registered nurse
2.3
57.8
717
3785
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
28.9
54.3
74
26
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.6
53.0
265
800
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
4.1
51.2
215
558
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
178.0
50.8
53
*
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.7
49.1
234
678
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
5.5
47.6
148
281
N06AB06
ATC
sertraline; oral
2.8
46.8
329
1259
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.3
46.4
257
835
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.5
46.1
429
1928
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
4.1
46.1
190
484
XKC03
NOMESCO Finland
Water cystometry
9.9
44.7
92
95
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.8
44.2
155
336
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.7
43.8
334
1338
N06AX12
ATC
bupropion; oral
3.3
43.7
242
784
N06AX11
ATC
mirtazapine; oral
2.2
43.2
547
2846
N05BA04
ATC
oxazepam; oral
2.3
42.9
453
2163
N06AX16
ATC
venlafaxine; oral
2.6
42.7
347
1443
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.9
42.5
184
489
F84.5
ICD-10 Finland
Asperger syndrome
12.2
42.3
78
65
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.6
42.1
204
597
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.1
41.5
137
278
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
5.2
41.4
134
266
N03AX09
ATC
lamotrigine; oral
3.7
41.1
192
545
F92.0
ICD-10 Finland
Depressive conduct disorder
408.5
41.0
41
*
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
408.5
41.0
41
*
IGY99
NOMESCO Finland
Other psychiatric treatment contact
4.4
41.0
158
377
ZYC01
NOMESCO Finland
Remote contact by phone
3.8
40.9
183
501
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.9
40.5
177
474
3076A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Enuresis[YÖKASTELU]
+∞
40.5
39
*
IGY02
NOMESCO Finland
Psychiatric monitoring contact
4.0
39.7
166
428
N03AG01
ATC
valproic acid; systemic, rectal
3.7
39.6
186
530
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.4
39.5
210
660
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
3.6
39.4
187
538
Z3226
NOMESCO Finland
Physiotherapist
2.2
39.1
448
2215
N06AB10
ATC
escitalopram; oral
2.1
39.0
530
2827
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.4
39.0
205
639
1530
FHL
Urethrocystoscopy
16.7
37.8
61
37
IGP01
NOMESCO Finland
Psychiatric family contact
6.1
37.8
107
181
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.5
37.8
141
326
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
5.8
36.4
106
186
3076B
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Enuresis[PÄIVÄKASTELU]
+∞
36.3
35
*
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
22.8
35.9
52
23
3077A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Encopresis
+∞
35.3
34
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.3
35.3
187
586
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.3
35.2
366
1718
N06AB04
ATC
citalopram; systemic
2.4
35.2
333
1492
Z2221
NOMESCO Finland
Medical doctor
2.0
35.0
587
3383
XA800
NOMESCO Finland
Neuropsychological investigation
3.5
35.0
174
519
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
347.1
34.8
35
*
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
5.4
34.3
106
200
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.7
33.6
155
435
N06BA12
ATC
lisdexamfetamine; oral
27.2
33.5
46
17
N39.4
ICD-10 Finland
Other specified urinary incontinence
5.8
32.7
95
166
IGV01
NOMESCO Finland
Psychiatric network contact
6.5
32.7
87
136
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
4.2
32.2
127
310
N06BA09
ATC
atomoxetine; oral
54.3
32.1
38
7
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.4
31.8
165
508
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
4.3
31.6
121
287
N05AF03
ATC
chlorprothixene; systemic
6.4
31.4
85
136
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.4
31.0
157
474
UKC02
NOMESCO Finland
Cystoscopy
3.2
30.4
167
536
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.7
29.7
105
230
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
4.0
29.3
122
313
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.3
29.0
151
466
IEV99
NOMESCO Finland
Other psychiatric network intervention
8.0
28.8
66
83
R5599
NOMESCO Finland
Other rehabilitation service
5.2
28.6
91
178
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
27.9
607
3778
P29
ICPC
Psychological sympt/compl other
2.4
27.7
248
1075
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
5.0
27.7
92
189
F91.9
ICD-10 Finland
Conduct disorder, unspecified
144.5
27.5
29
*
N06AX21
ATC
duloxetine; oral
2.7
27.2
192
727
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
3.5
27.1
130
377
N05AH02
ATC
clozapine; systemic
5.1
27.0
88
177
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
26.9
811
5562
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
5.6
26.6
79
143
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.6
25.5
119
337
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
25.5
238
1052
F83
ICD-10 Finland
Mixed specific developmental disorders
4.3
25.5
96
225
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
4.1
25.4
101
249
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
3.8
25.2
112
305
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.2
25.1
139
450
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
8.5
25.0
55
65
G04AC01
ATC
NA
5.7
24.9
73
130
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
+∞
24.9
24
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
24.8
342
1798
F99
ICD-10 Finland
Mental disorder, not otherwise specified
4.4
24.3
90
207
J01EA01
ATC
trimethoprim; systemic
1.9
24.1
406
2304
IEP99
NOMESCO Finland
Other psychiatric family intervention
6.6
24.0
62
94
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.5
23.3
194
807
F90.8
ICD-10 Finland
Other hyperkinetic disorders
46.5
23.2
28
6
N05BA01
ATC
diazepam; systemic, rectal
2.4
23.0
204
876
SPAT1389
SPAT
Visit based on need for special support
2.2
22.6
244
1155
N05AA02
ATC
levomepromazine; systemic
4.3
22.6
86
204
ZXE00
NOMESCO Finland
One hour or less
1.6
22.6
799
5651
N05CF01
ATC
zopiclone; oral
2.0
22.5
318
1685
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
22.5
666
4491
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
4.4
22.4
82
187
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
22.2
162
626
F40.1
ICD-10 Finland
Social phobias
3.0
22.1
133
455
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
6.5
22.1
58
90
F88
ICD-10 Finland
Other disorders of psychological development
13.6
22.1
38
28
F82
ICD-10 Finland
Specific developmental disorder of motor function
4.7
22.0
76
164
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
21.8
361
2031
N05BE01
ATC
buspirone; oral
5.4
21.6
66
124
J01XE01
ATC
nitrofurantoin; oral
6.3
21.6
58
93
C07AA05
ATC
propranolol; systemic
1.9
21.6
385
2221
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.3
21.4
212
962
SPAT1240
SPAT
Therapeutic discussion
1.8
21.3
391
2274
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
20.8
561
3674
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
+∞
20.7
20
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
20.4
374
2172
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.9
20.1
127
449
N05AN01
ATC
lithium; oral
4.6
20.0
70
153
R62.0
ICD-10 Finland
Delayed milestone
3.4
19.9
99
297
XA820
NOMESCO Finland
NA
17.2
19.8
31
18
N06AB05
ATC
paroxetine; oral
3.0
19.8
116
391
F50.9
ICD-10 Finland
Eating disorder, unspecified
3.7
19.8
88
241
F60.9
ICD-10 Finland
Personality disorder, unspecified
5.2
19.7
62
121
F98.1
ICD-10 Finland
Nonorganic encopresis
+∞
19.7
19
*
N03AX16
ATC
pregabalin; oral
2.0
19.6
261
1350
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.9
19.5
126
451
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
19.4
462
2911
P99
ICPC
Psychological disorders other
3.3
19.4
99
303
WX110
NOMESCO Finland
Local anesthesy
1.5
19.2
1577
13361
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
6.6
19.1
49
74
P01
ICPC
Feeling anxious/nervous/tense
1.7
19.0
498
3223
A06AD11
ATC
lactulose; oral
2.4
19.0
167
714
Z63.5
ICD-10 Finland
Disruption of family by separation and divorce
10.3
18.9
37
36
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
4.8
18.8
63
132
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
18.8
208
994
Z07
ICPC
Education problem
3.8
18.7
81
217
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
4.0
18.7
75
188
F93.1
ICD-10 Finland
Phobic anxiety disorder of childhood
27.6
18.6
25
9
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
18.5
185
843
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
8.2
18.5
41
50
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
18.4
420
2607
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
18.4
337
1955
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.5
18.1
64
142
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
18.1
201
960
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
18.1
516
3410
N06AX26
ATC
vortioxetine; oral
2.4
17.9
157
669
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.5
17.7
63
141
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
+∞
17.6
17
*
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
6.6
17.6
45
68
F89
ICD-10 Finland
Unspecified disorder of psychological development
17.9
17.6
27
15
K59.09
ICD-10 Finland
Constipation, unspecified
2.9
17.6
108
376
ZXA10
NOMESCO Finland
Bilateral
1.8
17.5
309
1767
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.5
17.5
62
138
N03AE01
ATC
clonazepam; systemic
3.3
17.5
91
283
R4110
NOMESCO Finland
Physiotherapy
1.7
17.4
429
2718
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.2
17.4
189
893
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.0
17.4
242
1269
R11
ICD-10 Finland
Nausea and vomiting
2.1
17.4
209
1032
602
Kela drug reimbursment
Children's severe malnutrition
3.9
17.4
73
191
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
17.4
341
2017
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
4.8
17.3
58
122
P76
ICPC
Depressive disorder
2.1
17.2
200
976
F80.2
ICD-10 Finland
Receptive language disorder
4.6
17.2
60
132
IEP03
NOMESCO Finland
Focused parental counselling
5.2
17.2
53
102
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
3.5
17.0
81
235
F39
ICD-10 Finland
Unspecified mood [affective] disorder
3.4
17.0
83
246
N05BA06
ATC
lorazepam; systemic, sublingual
3.9
17.0
71
185
P23
ICPC
Adolescent behaviour sympt/compl
4.9
16.9
55
112
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
4.9
16.9
55
112
R51.80
ICD-10 Finland
Headache
1.7
16.9
389
2416
F81.0
ICD-10 Finland
Specific reading disorder
5.9
16.9
47
80
XKD06
NOMESCO Finland
Physiologic investigation of micturition
5.9
16.9
47
80
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
6.4
16.8
44
69
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
16.8
1660
14385
R35
ICD-10 Finland
Polyuria
3.3
16.8
84
254
F94.8
ICD-10 Finland
Other childhood disorders of social functioning
+∞
16.6
16
*
F91.0
ICD-10 Finland
Conduct disorder confined to the family context
+∞
16.6
16
*
ZY000
NOMESCO Finland
Hospital inpatient
3.9
16.5
69
180
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
3.6
16.5
74
205
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
16.4
134
553
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
16.3
350
2128
XF600
NOMESCO Finland
Bloodpressure measurement
2.2
16.3
170
788
F84.8
ICD-10 Finland
Other pervasive developmental disorders
13.3
16.3
28
21
F61.0
ICD-10 Finland
Mixed personality disorders
4.7
16.2
55
118
SPAT1307
SPAT
Psychosocial counselling and guidance
1.8
16.1
324
1930
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
16.1
320
1899
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
15.8
806
6073
R03AC02
ATC
salbutamol; inhalant
1.4
15.8
1057
8412
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
15.8
291
1687
Z61.8
ICD-10 Finland
Other negative life events in childhood
10.0
15.7
31
31
IEP02
NOMESCO Finland
Child-centred family therapy
5.0
15.7
50
100
F31.8
ICD-10 Finland
Other bipolar affective disorders
3.7
15.6
69
189
F91.3
ICD-10 Finland
Oppositional defiant disorder
+∞
15.5
15
*
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
3.5
15.5
72
206
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
15.3
196
994
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.5
15.2
123
504
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
5.6
15.2
44
79
S18
ICPC
Laceration/cut
1.5
15.0
634
4577
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
7.4
15.0
35
47
N05AB03
ATC
perphenazine; systemic, rectal
3.8
15.0
64
171
K59.0
ICD-10 Finland
Constipation
2.6
14.9
111
434
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.6
14.9
109
424
R50.9
ICD-10 Finland
Fever, unspecified
1.7
14.8
351
2194
P72
ICPC
Schizophrenia
4.6
14.7
51
112
RS140
NOMESCO Finland
NA
7.5
14.7
34
45
RD210
NOMESCO Finland
NA
2.7
14.7
102
382
R4120
NOMESCO Finland
Occupational therapy
2.4
14.7
123
515
H01AC01
ATC
somatropin; parenteral
3.9
14.6
59
150
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
3.3
14.6
73
222
F34.1
ICD-10 Finland
Dysthymia
3.0
14.5
84
283
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
14.4
267
1548
D12
ICPC
Constipation
3.8
14.4
61
162
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.1
14.4
161
771
F80.1
ICD-10 Finland
Expressive language disorder
3.4
14.4
69
203
N30.0
ICD-10 Finland
Acute cystitis
1.8
14.3
256
1465
R53
ICD-10 Finland
Malaise and fatigue
1.7
14.3
357
2260
RS210
NOMESCO Finland
NA
8.3
14.3
31
37
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
8.3
14.3
31
37
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.4
14.2
125
533
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
14.2
308
1874
U02
ICPC
Urinary frequency/urgency
1.8
14.2
246
1397
P03
ICPC
Feeling depressed
1.7
14.1
346
2178
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
3.9
14.1
58
150
N04AA02
ATC
biperiden; systemic
4.8
14.1
46
95
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
8.1
14.1
31
38
204
Kela drug reimbursment
Leukemia lymphatica
4.3
14.0
51
118
78620
ICD-8 Finland
Symptoms referable to genito-urinary system, Enuresis
42.1
14.0
17
*
SPAT1234
SPAT
Support of social functional capacity
3.2
13.9
74
236
F41.00
ICD-10 Finland
Moderate panic disorder
3.5
13.9
65
188
N05CD07
ATC
temazepam; oral
3.1
13.8
75
242
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
3.3
13.8
69
210
D01
ICPC
Abdominal pain/cramps general
1.6
13.8
350
2226
J01CA08
ATC
pivmecillinam; oral
1.5
13.7
646
4753
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.6
13.6
393
2585
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
2.4
13.6
115
482
IGY02
SPAT
NA
6.0
13.6
37
62
T82
ICPC
Obesity
2.7
13.4
89
328
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.2
13.4
141
660
N02BE01
ATC
paracetamol; systemic, rectal
1.4
13.1
1398
11938
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.9
13.1
205
1123
F41.8
ICD-10 Finland
Other specified anxiety disorders
2.5
13.0
101
407
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
13.0
396
2637
ZXD05
NOMESCO Finland
Urgent procedure
1.5
13.0
540
3866
C03CA01
ATC
furosemide; systemic
2.2
12.9
135
629
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
4.7
12.8
43
92
F95.9
ICD-10 Finland
Tic disorder, unspecified
22.3
12.8
18
8
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.7
12.6
261
1565
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
12.6
618
4574
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
12.6
995
8044
R4190
NOMESCO Finland
Nutritional therapy
2.1
12.5
148
726
P81
ICPC
Hyperkinetic disorder
5.1
12.5
39
77
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
12.5
278
1700
N01
ICPC
Headache
1.5
12.5
500
3545
F98.6
ICD-10 Finland
Cluttering
+∞
12.4
12
*
F51.0
ICD-10 Finland
Nonorganic insomnia
1.7
12.4
264
1594
WX290
NOMESCO Finland
Other blockade of nerve
1.4
12.4
1114
9195
SPAT1243
SPAT
Psychiatric/psychological examination
2.2
12.4
124
568
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
9.9
12.3
24
24
E66.8
ICD-10 Finland
Other obesity
2.6
12.3
92
363
P74
ICPC
Anxiety disorder/anxiety state
2.1
12.3
146
718
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
12.2
479
3378
R03BA05
ATC
fluticasone; inhalant
1.5
12.2
417
2849
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
12.1
241
1428
U04
ICPC
Incontinence urine
3.9
12.0
49
127
A02BC02
ATC
pantoprazole; systemic
1.4
12.0
763
5921
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
12.0
1276
10814
RS214
NOMESCO Finland
NA
7.7
12.0
27
35
F90
ICD-10 Finland
Hyperkinetic disorders
26.4
11.9
16
6
R15
ICD-10 Finland
Faecal incontinence
6.9
11.9
29
42
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
11.8
458
3220
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
3.5
11.7
54
155
P27
ICPC
Fear of mental disorder
3.6
11.7
52
145
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
4.8
11.7
38
79
L03
ICPC
Low back symptom/complaint
1.5
11.7
442
3091
D09
ICPC
Nausea
1.8
11.7
209
1197
N05AD01
ATC
haloperidol; systemic
4.0
11.7
46
116
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
11.6
231
1367
RT420
NOMESCO Finland
NA
10.4
11.6
22
21
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
4.4
11.5
41
94
ZXY61
NOMESCO Finland
2-person team, special workers
8.0
11.4
25
31
F93.0
ICD-10 Finland
Separation anxiety disorder of childhood
+∞
11.4
11
*
IEP01
NOMESCO Finland
Psychoeducation, family
6.4
11.4
29
45
R03BA02
ATC
budesonide; inhalant
1.6
11.4
320
2082
F95.1
ICD-10 Finland
Chronic motor or vocal tic disorder
118.7
11.4
12
*
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
6.1
11.3
30
49
WX002
NOMESCO Finland
Sedation and analgesia
1.7
11.3
231
1376
IEY01
NOMESCO Finland
Psychoeducation, individual
3.8
11.2
46
120
ICB03
SPAT
NA
14.9
11.2
18
12
TKC50
NOMESCO Finland
Training of urinary bladder
34.7
11.2
14
*
K02.1
ICD-10 Finland
Caries of dentine
1.4
11.2
1342
11533
N05BA12
ATC
alprazolam; oral
2.2
11.1
113
521
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
11.1
237
1431
F50.1
ICD-10 Finland
Atypical anorexia nervosa
3.9
11.1
44
112
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.3
11.0
101
443
E66.01
ICD-10 Finland
Obesity due to excess calories
1.9
10.9
156
826
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
9.9
10.9
21
21
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
4.7
10.9
36
77
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
10.8
1124
9415
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.7
10.8
72
267
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
10.7
325
2156
P80
ICPC
Personality disorder
7.7
10.7
24
31
Z72.8
ICD-10 Finland
Other problems related to lifestyle
5.9
10.7
29
49
M54.5
ICD-10 Finland
Low back pain
1.4
10.7
513
3758
K03.66
ICD-10 Finland
Tooth plaque
1.7
10.7
214
1269
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.8
10.7
44
116
M79.6
ICD-10 Finland
Pain in limb
1.4
10.6
521
3833
D11
ICPC
Diarrhoea
1.6
10.6
303
1978
5640A
ICD-9 Finland
Functional digestive disorders, not elsewhere classified, Constipation
12.7
10.5
18
14
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
2.5
10.5
79
315
A04
ICPC
Weakness/tiredness general
1.6
10.5
309
2034
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
4.1
10.5
39
94
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.6
10.4
73
277
P19
ICPC
Drug abuse
3.5
10.4
48
139
SPAT1229
SPAT
Assessment of need for aid
2.8
10.4
65
232
G04BD07
ATC
tolterodine; oral
4.8
10.3
33
68
U13
ICPC
Bladder symptom/complaint other
3.4
10.3
49
145
F32.8
ICD-10 Finland
Other depressive episodes
3.4
10.3
49
145
U07
ICPC
Urine symptom/complaint other
2.4
10.3
86
361
ZXA00
NOMESCO Finland
Right side
1.6
10.3
279
1799
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.7
10.3
69
257
M79.7
ICD-10 Finland
Fibromyalgia
3.0
10.3
57
189
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
4.4
10.2
36
82
F41.3
ICD-10 Finland
Other mixed anxiety disorders
2.9
10.2
61
212
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.8
10.2
182
1039
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
4.0
10.2
40
101
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.3
10.2
93
407
IDP99
NOMESCO Finland
Other psychotherapeutic family intervention
10.5
10.2
19
18
SPAT1369
SPAT
Meeting with student welfare group of educational institution
4.1
10.2
38
92
TJD20
NOMESCO Finland
Change of gastrostomy tube
5.4
10.1
29
53
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
3.8
10.1
41
107
D10
ICPC
Vomiting
1.7
10.1
237
1474
Z61.5
ICD-10 Finland
Problems related to alleged sexual abuse of child by person outside primary support group
13.0
10.1
17
13
R1260
NOMESCO Finland
Evaluation of communicative skills
4.0
10.0
39
98
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
10.0
933
7650
RS220
NOMESCO Finland
NA
3.2
10.0
51
160
JDB10
NOMESCO Finland
Percutaneous gastrostomy
5.3
10.0
29
54
WX882
NOMESCO Finland
High dependency care
2.1
10.0
116
568
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
9.9
77
312
F98
ICD-10 Finland
Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence
39.5
9.9
12
*
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
39.5
9.9
12
*
RL140
NOMESCO Finland
NA
4.5
9.9
34
76
R74
ICPC
Upper respiratory infection acute
1.3
9.9
861
6982
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
9.9
161
894
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.0
9.8
128
655
P28
ICPC
Limited function/disability (P)
5.1
9.8
30
59
F31
ICD-10 Finland
Bipolar affective disorder
4.2
9.8
36
86
ZXY60
NOMESCO Finland
2-person team, nurses
4.2
9.8
36
86
P24
ICPC
Specific learning problem
2.8
9.8
62
224
A28
ICPC
Limited function/disability NOS
2.1
9.7
105
496
Z50.5
ICD-10 Finland
Speech therapy
2.4
9.7
77
316
N06AX05
ATC
trazodone; oral
3.4
9.7
45
131
R4170
NOMESCO Finland
Therapy forms involving educational rehabilitation
25.7
9.7
13
5
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
1.7
9.7
190
1120
N03AX12
ATC
gabapentin; oral
1.8
9.7
154
848
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
5.2
9.7
29
56
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.9
9.7
147
799
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.1
9.7
107
513
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
3.1
9.6
50
159
IER01
NOMESCO Finland
Psychoeducation, group
4.2
9.6
35
83
F91.2
ICD-10 Finland
Socialized conduct disorder
54.4
9.6
11
*
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
4.9
9.6
30
61
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
9.6
1193
10194
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.1
9.5
50
160
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.3
9.5
84
364
J01MA02
ATC
ciprofloxacin; systemic
1.5
9.5
402
2868
R4140
NOMESCO Finland
Psychotherapy
4.4
9.5
33
75
R06.0
ICD-10 Finland
Dyspnoea
1.6
9.4
280
1846
P12
ICPC
Bedwetting/enuresis
6.3
9.4
24
38
Z04.6
ICD-10 Finland
General psychiatric examination, requested by authority
9.9
9.4
18
18
AA1AD
NOMESCO Finland
CT of head and brain
1.7
9.4
203
1230
G47.3
ICD-10 Finland
Sleep apnoea
1.7
9.4
190
1131
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
5.6
9.4
26
46
F50.2
ICD-10 Finland
Bulimia nervosa
4.0
9.4
36
90
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
3.9
9.3
37
95
N05CF02
ATC
zolpidem; oral
1.7
9.3
198
1196
ZXD20
NOMESCO Finland
Day surgery
1.7
9.3
201
1218
30899
ICD-8 Finland
Behaviour disorders of childhood
+∞
9.3
9
*
F91.1
ICD-10 Finland
Unsocialized conduct disorder
+∞
9.3
9
*
F98.40
ICD-10 Finland
Movement stereotypes do not hurt themselves
+∞
9.3
9
*
F94.1
ICD-10 Finland
Reactive attachment disorder of childhood
+∞
9.3
9
*
RT390
NOMESCO Finland
NA
+∞
9.3
9
*
R33
ICD-10 Finland
Retention of urine
3.2
9.3
48
152
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
3.3
9.3
45
136
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
4.4
9.3
32
72
J01DA01
ATC
[U] cefalexin; systemic
1.3
9.3
983
8188
N18.8
ICD-10 Finland
Other chronic renal failure
4.1
9.3
35
86
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
9.3
290
1938
F21
ICD-10 Finland
Schizotypal disorder
6.1
9.2
24
39
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
3.6
9.2
40
111
K04.0
ICD-10 Finland
Pulpitis
1.7
9.2
214
1324
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
8.6
9.2
19
22
E66.9
ICD-10 Finland
Obesity, unspecified
2.4
9.1
73
302
R05
ICD-10 Finland
Cough
1.5
9.1
336
2326
A01
ICPC
Pain general/multiple sites
1.9
9.1
125
655
X84
ICD-10 Finland
Intentional self-harm by unspecified means
7.2
9.1
21
29
U01
ICPC
Dysuria/painful urination
1.8
9.1
167
965
J01DB01
ATC
cefalexin; oral
1.3
9.1
1600
14328
A02BC01
ATC
omeprazole; systemic
1.5
9.1
309
2101
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
9.1
134
720
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
9.1
441
3231
SPAT1254
SPAT
Administration of medicine
1.5
9.1
381
2711
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
4.3
9.1
32
74
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.6
9.0
39
108
A10BA02
ATC
metformin; oral
1.7
9.0
168
978
C07AB07
ATC
bisoprolol; oral
1.5
9.0
295
1990
SPAT1281
SPAT
Other administrative function
1.7
8.9
176
1039
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
8.9
111
560
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.0
8.9
108
537
Y0699
ICD-8 Finland
Examination of the urinary and genital organs, Urinary organs. Does not include urine tests to determine endocrine and metabolic disorders (Y 00.99)
6.9
8.9
21
30
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
3.1
8.9
47
152
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.7
8.9
60
224
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
3.4
8.9
41
120
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
8.9
551
4215
Z61.2
ICD-10 Finland
Altered pattern of family relationships in childhood
18.4
8.9
13
7
R1270
NOMESCO Finland
Evaluation of the need for educational rehabilitation
23.7
8.8
12
5
ZXY02
NOMESCO Finland
Neuropsychologist
6.4
8.8
22
34
F32.1
ICD-10 Finland
Moderate depressive episode
1.8
8.8
154
875
A03FA02
ATC
cisapride; oral, rectal
2.2
8.8
87
398
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.5
8.8
378
2701
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
5.0
8.8
27
54
T90
ICPC
Diabetes non-insulin dependent
1.9
8.8
128
687
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.3
8.8
31
72
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
4.3
8.8
31
72
TK800
NOMESCO Finland
Hemodialysis
3.8
8.8
35
91
N03AF02
ATC
oxcarbazepine; oral
2.4
8.7
71
297
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.4
8.7
527
4012
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
8.7
999
8388
Q62.7
ICD-10 Finland
Congenital vesico-uretero-renal reflux
4.7
8.7
28
59
P22
ICPC
Child behaviour symptom/complaint
2.4
8.7
70
291
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
8.7
401
2904
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
8.7
201
1242
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
8.7
253
1663
RT160
NOMESCO Finland
NA
4.2
8.6
31
73
N07BA03
ATC
varenicline; oral
2.2
8.6
83
375
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
2.9
8.6
50
171
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
8.6
399
2893
ZXY03
NOMESCO Finland
Occupational therapist
5.3
8.6
25
47
G44.2
ICD-10 Finland
Tension-type headache
1.6
8.6
227
1453
U05
ICPC
Urination problems other
2.9
8.6
51
178
N30.9
ICD-10 Finland
Cystitis, unspecified
2.1
8.6
91
431
J01MA12
ATC
levofloxacin; systemic
1.8
8.6
157
907
N07BB01
ATC
disulfiram; oral
2.5
8.6
63
250
127
Kela drug reimbursment
Transplant complication
3.0
8.6
46
151
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
6.5
8.5
21
32
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.3
8.5
41
124
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
3.3
8.5
41
124
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
4.8
8.5
27
56
Z71.8
ICD-10 Finland
Other specified counselling
1.4
8.5
523
3987
SGA01
NOMESCO Finland
Tooth opening as first aid
1.5
8.5
297
2029
P01AB01
ATC
metronidazole; oral, rectal
1.4
8.5
502
3800
ZXY57
NOMESCO Finland
2-person team, nurse-social worker
6.1
8.5
22
36
H01
ICPC
Ear pain/earache
1.5
8.4
340
2399
N03AX11
ATC
topiramate; oral
2.6
8.4
61
238
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
19.8
8.4
12
6
N06AA09
ATC
amitriptyline; systemic
2.3
8.4
73
314
D06
ICPC
Abdominal pain localized other
1.7
8.4
174
1044
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
3.5
8.4
37
105
N06AA04
ATC
clomipramine; systemic
5.1
8.3
25
49
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.9
8.3
122
655
A05
ICPC
Feeling ill
1.5
8.3
319
2226
RS310
NOMESCO Finland
NA
12.6
8.3
14
11
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
4.3
8.3
29
67
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
3.7
8.3
34
91
L02
ICPC
Back symptom/complaint
1.6
8.3
205
1293
E34.35
ICD-10 Finland
Abnormal growth retardation
2.8
8.2
52
187
A12AA04
ATC
calcium carbonate; oral
4.0
8.2
31
77
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.7
8.2
185
1137
N03AF01
ATC
carbamazepine; oral, rectal
2.7
8.2
53
196
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
7.0
8.1
19
27
-1
NOMESCO Finland
NA
1.3
8.1
975
8211
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.2
8.1
75
335
R42
ICD-10 Finland
Dizziness and giddiness
1.6
8.1
223
1443
Z94.0
ICD-10 Finland
Kidney transplant status
3.5
8.1
36
103
P86
ICPC
Anorexia nervosa/bulimia
3.8
8.1
32
83
P06
ICPC
Sleep disturbance
1.6
8.1
195
1219
XKD03
NOMESCO Finland
Urethral pressure profilometry
4.9
8.1
25
51
ZXY58
NOMESCO Finland
2-person team, nurse-occupational therapist
7.4
8.1
18
24
R2110
NOMESCO Finland
Giving the first information
1.9
8.0
116
620
B03XA01
ATC
erythropoietin; parenteral
5.1
8.0
24
47
F50.8
ICD-10 Finland
Other eating disorders
4.0
8.0
30
74
IEP04
NOMESCO Finland
Focused parenting intervention
5.6
8.0
22
39
BE00A
NOMESCO Finland
NA
11.5
8.0
14
12
F81.1
ICD-10 Finland
Specific spelling disorder
8.0
8.0
17
21
XF602
NOMESCO Finland
Bloodpressure monitoring
3.7
8.0
33
89
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.9
8.0
47
164
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
8.8
7.9
16
18
F20.10
ICD-10 Finland
Raise schizophrenia continuously
9.9
7.9
15
15
59010
ICD-8 Finland
Infections of kidney, Pyelonephritis
4.8
7.9
25
52
N05AE04
ATC
ziprasidone; systemic
5.0
7.9
24
48
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
7.9
329
2335
H52.0
ICD-10 Finland
Hypermetropia
2.3
7.9
68
294
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.1
7.9
88
428
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
3.0
7.9
42
138
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.5
7.8
282
1943
A29
ICPC
General symptom/complaint other
1.7
7.8
167
1013
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
3.3
7.8
37
112
K03.00
ICD-10 Finland
Approximal wear
2.1
7.8
87
423
SPAT1216
SPAT
Assessment of functional ability
1.8
7.7
141
814
IHZ04
SPAT
NA
4.5
7.7
26
58
F50.3
ICD-10 Finland
Atypical bulimia nervosa
4.5
7.7
26
58
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
3.0
7.7
41
135
F84.10
ICD-10 Finland
Autism in atypical age
44.4
7.7
9
*
L04AA06
ATC
mycophenolic acid; systemic
2.9
7.7
44
150
J45.1
ICD-10 Finland
Nonallergic asthma
1.7
7.6
152
903
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
2.5
7.6
56
222
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.5
7.6
56
222
RS222
NOMESCO Finland
NA
3.3
7.6
36
109
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
5.2
7.6
22
42
A03
ICPC
Fever
1.3
7.6
535
4166
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
7.5
185
1161
L28
ICPC
Limited function/disability (L)
1.8
7.5
129
732
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
3.4
7.5
34
99
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
3.9
7.5
29
74
H02AB09
ATC
hydrocortisone; systemic
2.2
7.5
75
345
F94.0
ICD-10 Finland
Elective mutism
24.7
7.5
10
*
A11CC03
ATC
alfacalcidol; systemic
2.9
7.5
43
146
X78
ICD-10 Finland
Intentional self-harm by sharp object
3.7
7.5
31
84
F32
ICD-10 Finland
Depressive episode
1.8
7.5
123
689
R96
ICPC
Asthma
1.8
7.5
128
724
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.8
7.5
115
628
N02AX02
ATC
tramadol; systemic, rectal
1.4
7.5
410
3058
Z63.2
ICD-10 Finland
Inadequate family support
8.7
7.5
15
17
C09AA02
ATC
enalapril; systemic
1.9
7.4
103
541
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.4
7.4
25
56
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.1
7.4
82
396
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
7.4
798
6599
SPAT1283
SPAT
Restricted health certificate
1.3
7.4
651
5236
Z61.7
ICD-10 Finland
Personal frightening experience in childhood
7.0
7.4
17
24
C08CA02
ATC
felodipine; oral
2.9
7.4
43
149
F98.12
ICD-10 Finland
Non-organic encopres with very loose stools
79.1
7.4
8
*
N06BA02
ATC
dexamfetamine; oral
79.1
7.4
8
*
N06AX22
ATC
agomelatine; oral
2.6
7.4
52
203
WX892
NOMESCO Finland
Monitored bed care
1.9
7.3
110
594
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
3.9
7.3
28
71
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.3
7.3
612
4882
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.5
7.3
299
2114
L01
ICPC
Neck symptom/complaint
1.5
7.3
242
1634
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.5
7.3
217
1432
ZXY49
NOMESCO Finland
Other health care provider
4.2
7.3
26
62
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
7.3
61
261
A41.9
ICD-10 Finland
Sepsis, unspecified
2.5
7.3
54
216
F93.2
ICD-10 Finland
Social anxiety disorder of childhood
+∞
7.3
7
*
F91.8
ICD-10 Finland
Other conduct disorders
+∞
7.3
7
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
7.2
228
1525
WZA90
NOMESCO Finland
Other doctors statement
1.3
7.2
553
4355
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
7.2
534
4181
F34.0
ICD-10 Finland
Cyclothymia
6.7
7.2
17
25
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
6.7
7.2
17
25
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.6
7.2
170
1059
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
6.2
7.1
18
29
U71
ICPC
Cystitis/urinary infection other
1.9
7.1
99
524
RS211
NOMESCO Finland
NA
3.6
7.1
30
83
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
5.4
7.1
20
37
F95.0
ICD-10 Finland
Transient tic disorder
29.6
7.1
9
*
J20
ICD-10 Finland
Acute bronchitis
1.7
7.1
130
754
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.9
7.1
104
559
TKC52
NOMESCO Finland
Patient education concerning pelvic floor contraction exercises
19.8
7.1
10
5
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.2
7.1
35
110
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
7.1
90
461
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
2.5
7.0
53
214
ICA04
NOMESCO Finland
Psychiatric treatment plan, psychotherapy supported by Social Insurance Institution
4.7
7.0
22
46
T74.1
ICD-10 Finland
Physical abuse
2.3
7.0
62
272
R21
ICPC
Throat symptom/complaint
1.3
7.0
707
5784
Z10.1
ICD-10 Finland
Routine general health check-up of inhabitants of institutions
11.9
7.0
12
10
C03DA01
ATC
spironolactone; oral
2.1
7.0
72
339
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
7.0
127
733
IAA02
NOMESCO Finland
Consultation concerning further psychiatric treatment
5.9
7.0
18
30
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
7.0
181
1157
5990C
ICD-9 Finland
Other disorders of urethra and urinary tract, Urinary tract infection, site not specified[INFECTIO VIARUM URINARIUM RECIDIVANS]
9.9
7.0
13
13
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
4.0
6.9
26
65
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
3.4
6.9
31
90
L17
ICPC
Foot/toe symptom/complaint
1.4
6.9
447
3424
5901A
ICD-9 Finland
Infections of kidney, Acute pyelonephritis
3.8
6.9
27
70
R30.0
ICD-10 Finland
Dysuria
2.2
6.9
66
301
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
6.9
205
1353
H53.0
ICD-10 Finland
Amblyopia ex anopsia
2.6
6.8
46
176
N06AG02
ATC
moclobemide; oral
2.7
6.8
44
162
WX730
NOMESCO Finland
Conventional respirator
3.6
6.8
29
81
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
6.8
88
451
M25.5
ICD-10 Finland
Pain in joint
1.4
6.8
408
3086
RT250
NOMESCO Finland
NA
7.4
6.8
15
20
R63.3
ICD-10 Finland
Feeding difficulties and mismanagement
7.4
6.8
15
20
S29
ICPC
Skin symptom/complaint other
1.4
6.8
291
2074
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
3.3
6.8
32
97
Z31.5
ICD-10 Finland
Genetic counselling
1.7
6.8
127
740
H03AA01
ATC
levothyroxine sodium; systemic
1.5
6.8
240
1648
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
8.2
6.7
14
17
ZYB01
NOMESCO Finland
Outreach service at unit of same specialty
8.2
6.7
14
17
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
3.5
6.7
29
82
SPAT1260
SPAT
Consultation of another employee
1.4
6.7
302
2172
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
6.7
1042
8992
Z01
ICPC
Poverty/financial problem
10.8
6.7
12
11
A97
ICPC
No disease
1.4
6.7
366
2725
N39.3
ICD-10 Finland
Stress incontinence
2.4
6.7
54
227
ZXY54
NOMESCO Finland
2-person team, doctor-occupational therapist
16.5
6.7
10
6
FM2CE
NOMESCO Finland
NA
2.0
6.7
81
408
K06.18
ICD-10 Finland
Another gingival hyperplasia
4.5
6.7
22
49
S06.0
ICD-10 Finland
Concussion
1.5
6.7
226
1538
N06AX03
ATC
mianserin; oral
2.7
6.7
43
159
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.3
6.6
59
259
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.6
6.6
162
1020
RT150
NOMESCO Finland
NA
3.2
6.6
32
99
ZXY85
NOMESCO Finland
Other special worker in multidisciplinary team
22.2
6.6
9
*
Z94.1
ICD-10 Finland
Heart transplant status
7.1
6.6
15
21
R02
ICPC
Shortness of breath/dyspnoea
1.6
6.6
177
1140
L20.0
ICD-10 Finland
Besnier prurigo
1.4
6.6
271
1917
G04BD08
ATC
solifenacin; oral
2.8
6.6
39
138
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
6.6
681
5581
E34.31
ICD-10 Finland
Short stature, prenatal disorder
4.8
6.6
20
41
S76
ICPC
Skin infection other
2.1
6.5
69
330
1AB02
NOMESCO Finland
NA
5.8
6.5
17
29
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.1
6.5
33
106
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
5.4
6.5
18
33
F60.5
ICD-10 Finland
Anankastic personality disorder
3.3
6.5
30
90
WX402
NOMESCO Finland
General anaesthesia
1.4
6.5
296
2135
UJF32
NOMESCO Finland
Coloscopy
1.5
6.5
218
1477
P10
ICPC
Stammering/stuttering/tic
8.6
6.5
13
15
R39.1
ICD-10 Finland
Other difficulties with micturition
3.0
6.5
34
112
ZX199
NOMESCO Finland
Other rote
4.0
6.5
24
60
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
2.2
6.5
63
289
C08CA01
ATC
amlodipine; oral
1.6
6.5
160
1010
R52.9
ICD-10 Finland
Pain, unspecified
1.7
6.5
124
728
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
6.4
63
290
R1250
NOMESCO Finland
Evaluation of functional capability
2.8
6.4
38
135
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.2
6.4
58
259
GD1LA
NOMESCO Finland
GD
5.0
6.4
19
38
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
5.0
6.4
19
38
Z62.2
ICD-10 Finland
Institutional upbringing
69.0
6.4
7
*
M79.1
ICD-10 Finland
Myalgia
1.5
6.4
201
1343
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
3.5
6.4
27
76
F50.0
ICD-10 Finland
Anorexia nervosa
2.5
6.4
45
176
X14
ICPC
Vaginal discharge
2.0
6.3
74
367
EMB30
NOMESCO Finland
Adenotomy
1.5
6.3
236
1635
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.2
6.3
62
285
P11
ICPC
Eating problem in child
4.2
6.3
22
52
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
4.2
6.3
22
52
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
4.6
6.3
20
43
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.5
6.3
46
185
R4130
NOMESCO Finland
Speech therapy
2.4
6.3
48
196
U29
ICPC
Urinary symptom/complaint other
2.9
6.3
34
115
R05
ICPC
Cough
1.3
6.2
453
3530
E66
ICD-10 Finland
Obesity
2.0
6.2
75
375
Z00.0
ICD-10 Finland
General medical examination
1.4
6.2
362
2726
1603
FHL
Urodynamic research
+∞
6.2
6
*
3141A
ICD-9 Finland
Hyperkinetic syndrome of childhood, Hyperkinesis with developmental delay
+∞
6.2
6
*
F98.11
ICD-10 Finland
Non-organic encopres leave feces in inappropriate places
+∞
6.2
6
*
C02AC02
ATC
guanfacine; oral
+∞
6.2
6
*
A99
ICPC
Disease/condition unspecnature/site
1.7
6.2
117
687
Z08
ICPC
Social welfare problem
3.3
6.2
28
83
F41.09
ICD-10 Finland
UNS Panic Syndrome
1.9
6.2
87
462
59098
ICD-8 Finland
Infections of kidney, Alia definita
26.3
6.2
8
*
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.6
6.2
160
1023
J35.2
ICD-10 Finland
Hypertrophy of adenoids
1.6
6.1
172
1120
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
4.7
6.1
19
40
K04.1
ICD-10 Finland
Necrosis of pulp
1.6
6.1
159
1019
Z99.2
ICD-10 Finland
Dependence on renal dialysis
5.3
6.1
17
32
F60.8
ICD-10 Finland
Other specific personality disorders
4.4
6.1
20
45
Z29
ICPC
Social problem NOS
2.2
6.1
60
277
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.4
6.1
242
1701
ZXA05
NOMESCO Finland
Left side
1.5
6.0
231
1610
DFF00
NOMESCO Finland
Pure tone audiometry
1.8
6.0
90
490
N17
ICPC
Vertigo/dizziness
1.6
6.0
157
1005
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.1
6.0
67
326
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028707) Methadone [Presence] in Urine by Screen method
313
904
3.75
91.11
3.3
2.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
743
4055
2.14
60.58
4.2
3.7
mmol/l
8.3
8.7
0.95
671
3664
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1014
6291
1.98
57.50
12.7
8.0
mmol/l
1.2
1.2
0.15
959
5847
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1082
6874
1.96
57.17
11.7
7.8
mmol/l
1.2
1.2
0.23
946
6009
(3011288) Drugs identified in Urine by Screen method
383
1630
2.55
55.39
4.1
2.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
594
3138
2.13
51.53
2.2
1.7
%
1.4
1.3
5.38
545
2881
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
765
4437
2.00
51.44
1.8
1.6
pmol/l
96.3
98.5
0.67
450
2460
(3018418) pH of Serum or Plasma
632
3477
2.05
48.87
5.3
3.7
ph
7.4
7.4
0.29
117
632
(3019309) Folate [Moles/volume] in Red Blood Cells
338
1448
2.50
47.83
1.7
1.6
nmol/l
1176.5
1140.3
0.32
284
1117
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1879
14868
1.95
45.98
4.4
3.6
pmol/l
14.4
14.4
0.34
1763
13561
(3015377) Calcium [Moles/volume] in Serum or Plasma
726
4279
1.94
45.66
2.8
2.8
mmol/l
2.4
2.4
0.15
661
3880
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1530
11463
1.80
43.19
7.3
6.0
u/l
89.8
84.8
2.27
1453
10780
(1001926) Buprenorphine [Presence] in Urine by Screen method
395
1910
2.23
42.08
3.0
1.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2068
17104
2.04
41.85
5.1
4.1
mu/l
1.8
1.9
0.96
1979
16197
(3013826) Glucose [Moles/volume] in Serum or Plasma
1288
9280
1.75
40.62
6.7
5.1
mmol/l
6.1
6.2
0.15
1191
8359
(3024561) Albumin [Mass/volume] in Serum or Plasma
861
5528
1.81
40.43
6.5
5.8
g/l
37.5
37.7
0.49
800
5179
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1014
6847
1.77
40.00
3.3
2.6
nmol/l
66.8
69.6
2.89
961
6479
(3023103) Potassium [Moles/volume] in Serum or Plasma
2117
17743
2.06
39.97
15.7
9.3
mmol/l
3.9
3.9
0.29
2061
17070
(3019550) Sodium [Moles/volume] in Serum or Plasma
2109
17697
2.04
38.99
15.6
9.2
mmol/l
139.7
139.5
5.27
2060
17091
(3021960) Folate [Moles/volume] in Serum or Plasma
462
2448
2.05
38.60
1.6
1.4
nmol/l
20.5
20.1
0.08
425
2203
(3016879) Cocaine [Presence] in Urine
438
2290
2.07
37.89
3.0
1.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
557
3201
1.92
36.65
2.5
2.2
u/l
191.7
246.9
0.80
535
3060
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1017
7018
1.72
36.11
6.2
5.7
umol/l
12.0
13.2
0.83
948
6491
(3013650) Neutrophils [#/volume] in Blood by Automated count
1452
11029
1.70
35.94
12.3
8.9
e9/l
4.0
3.8
1.67
1270
9542
(3000764) Benzodiazepines [Presence] in Urine
458
2487
2.00
35.48
3.0
1.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1356
10148
1.68
35.19
9.6
7.3
e9/l
0.2
0.2
0.89
1206
8963
(3006315) Basophils [#/volume] in Blood
1316
9794
1.67
34.69
8.8
6.9
e9/l
0.0
0.0
0.09
1157
8507
(3028300) Cannabinoids [Presence] in Urine
459
2513
1.98
34.66
3.0
1.8
—
—
—
0
0
(4198724)
92
219
4.26
34.57
2.1
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
458
2510
1.98
34.47
3.0
1.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1310
9777
1.66
33.83
8.9
6.9
e9/l
0.6
0.5
2.12
1153
8500
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
846
5646
1.72
33.30
3.7
3.4
u/l
29.7
31.1
0.71
813
5396
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
829
5543
1.70
32.16
5.0
3.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
362
1876
2.05
31.69
2.3
2.2
nmol/l
355.6
369.9
0.72
335
1753
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1814
14866
1.71
31.56
3.6
2.7
mmol/l
5.6
5.5
1.53
1708
13852
(3044889) 12 lead EKG panel
1230
9144
1.63
31.36
3.0
2.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
79
182
4.39
30.97
13.8
13.8
nmol/l
736.8
812.5
0.75
79
174
(40758558) Short blood count panel - Blood
741
4847
1.72
30.93
8.9
7.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
695
4474
1.73
30.70
4.9
3.1
e6/l
0.2
0.2
0.24
540
3256
(3019198) Lymphocytes [#/volume] in Blood
1348
10300
1.62
30.35
8.8
6.8
e9/l
2.2
2.1
1.46
1202
9174
(3023368) Bacteria identified in Blood by Culture
527
3139
1.83
30.33
4.9
4.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
941
6584
1.65
30.27
8.3
7.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
439
2474
1.91
30.07
2.8
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
890
6150
1.66
30.00
5.6
3.7
e6/l
74.6
65.5
0.15
609
3952
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
643
4073
1.75
29.97
2.4
2.6
mg/l
2.8
2.6
1.58
570
3552
(3000850) Epithelial cells [#/volume] in Urine
544
3294
1.80
29.57
3.7
2.7
e6/l
10.4
7.7
1.82
486
2873
(3031040) Bacteria [#/volume] in Urine by Automated count
1497
11784
1.62
29.40
5.3
3.6
e6/l
258.4
1075.9
1.02
25
132
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
672
4335
1.72
29.23
2.9
2.5
u/l
62.7
56.1
0.48
619
4023
(3026008) Bacteria identified in Urine by Culture
677
4397
1.71
28.63
3.1
2.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
631
4026
1.73
28.45
3.7
2.9
kg/l
1.0
1.0
0.06
83
646
(3011397) Hemoglobin [Presence] in Urine by Test strip
645
4146
1.72
28.28
4.0
2.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
732
4900
1.66
27.41
5.0
3.2
e6/l
20.8
65.1
2.16
563
3639
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2226
19625
1.96
27.26
13.5
8.8
umol/l
68.1
67.5
0.41
2226
19614
(36304419) Bacteria [Presence] in Urine
690
4558
1.68
27.14
4.9
3.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
449
2627
1.83
27.10
4.1
2.7
e6/l
0.9
1.0
0.36
261
1373
(3037467) Urinalysis macro (dipstick) panel - Urine
1555
12480
1.59
27.05
5.0
3.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
392
2217
1.88
26.29
13.3
8.4
mmol/l
1.2
1.2
0.08
373
2118
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
69
166
4.18
25.61
11.0
10.6
mmol/l
0.6
0.6
0.61
63
156
(3006504) Eosinophils/100 leukocytes in Blood
1216
9348
1.54
24.61
8.7
7.0
%
2.9
2.9
0.00
1142
8839
(3019069) Monocytes/100 leukocytes in Blood
1223
9420
1.54
24.49
8.9
7.2
%
8.0
8.1
0.54
1156
8948
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1564
12724
1.55
24.30
3.9
3.0
u/l
34.5
32.5
0.75
1506
12214
(3022096) Basophils/100 leukocytes in Blood
1180
9033
1.54
24.20
8.8
7.1
%
0.6
0.6
0.36
1110
8552
(3009466) Valproate [Moles/volume] in Serum or Plasma
103
337
3.10
24.16
5.7
5.6
umol/l
393.3
399.0
0.15
89
302
(3012095) Magnesium [Moles/volume] in Serum or Plasma
369
2100
1.86
24.13
9.5
6.7
mmol/l
0.8
0.8
1.78
349
2004
(3022948) Iron [Moles/volume] in Serum or Plasma
388
2243
1.83
24.13
3.5
2.4
umol/l
13.8
14.8
1.91
371
2100
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
319
1747
1.92
23.46
2.5
2.3
mmol/l
2.4
2.4
0.18
266
1513
(3026782) Osmolality of Urine
501
3156
1.70
23.06
3.8
2.6
mosm/kgh2o
575.6
577.9
0.07
438
2703
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
95
305
3.15
23.02
2.9
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
349
1985
1.85
22.80
10.5
7.6
mmol/l
1.0
1.4
1.37
292
1589
(3020779) Urea [Moles/volume] in Serum or Plasma
275
1448
1.98
22.68
15.4
10.2
mmol/l
6.9
5.8
2.98
265
1408
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2217
19776
1.83
22.49
10.4
7.5
u/l
27.0
26.8
0.12
2167
19134
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1576
12954
1.53
22.43
4.4
3.4
mmol/mol
37.1
36.7
0.61
1510
12318
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
265
1385
1.99
22.31
3.4
3.7
g/l
0.2
0.2
0.98
248
1316
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
326
1831
1.87
22.13
3.9
2.6
%
21.8
24.1
2.31
298
1640
(3021447) Carbon dioxide [Partial pressure] in Venous blood
347
1990
1.83
22.03
10.5
7.6
kpa
5.9
5.8
0.16
334
1943
(3013707) Erythrocyte sedimentation rate by Westergren method
1536
12604
1.51
21.65
4.3
3.6
mm/h
8.5
7.6
2.22
1436
11772
(3024354) Oxygen [Partial pressure] in Venous blood
321
1819
1.85
21.14
10.2
7.5
kpa
5.1
5.0
0.22
308
1783
(3002030) Lymphocytes/100 leukocytes in Blood
1263
9992
1.49
21.02
8.6
6.8
%
32.0
32.2
0.34
1190
9487
(3018010) Neutrophils/100 leukocytes in Blood
1244
9828
1.49
20.75
8.4
6.6
%
53.6
53.5
0.08
1173
9356
(3004789) Transferrin [Mass/volume] in Serum or Plasma
346
2021
1.80
20.61
3.8
2.4
g/l
2.5
2.5
0.10
328
1888
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
419
2595
1.71
20.30
4.3
2.8
e6/l
4.3
3.5
0.61
233
1342
(3021589) Normoblasts [#/volume] in Blood
1159
9057
1.48
20.24
11.1
8.6
e9/l
0.0
0.0
0.83
934
7281
(3033658) Prothrombin time (PT) actual/Normal
603
4104
1.59
20.09
6.7
5.1
%
91.3
91.8
0.21
595
3995
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
289
1610
1.87
20.04
11.1
7.7
mmol/l
23.9
23.8
0.19
266
1549
(3000991) Gas panel - Venous blood
319
1844
1.81
19.62
14.5
9.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
364
2193
1.74
19.42
1.6
1.5
pmol/l
429.0
21333072.3
1.80
326
1936
(40761535) Cells panel - Urine sediment
196
967
2.08
19.29
3.4
2.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2293
20852
1.87
19.27
11.7
7.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1143
8981
1.46
18.99
3.9
3.0
estimate
0.0
0.0
1.08
224
1719
(3014111) Lactate [Moles/volume] in Serum or Plasma
235
1249
1.94
18.77
10.3
10.6
mmol/l
1.4
1.4
0.16
229
1171
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
320
1877
1.78
18.70
17.4
12.2
mmol/l
24.6
24.7
0.04
320
1870
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
507
3381
1.60
18.20
1.6
1.6
mmol/l
1.4
1.3
0.55
468
3056
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
255
1408
1.87
18.13
2.2
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
257
1429
1.86
17.87
2.2
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
604
4215
1.54
17.72
5.3
4.5
inr
1.1
1.1
0.35
198
1438
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2206
19942
1.69
17.50
14.3
9.2
mg/l
20.8
21.0
0.09
1680
14551
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
344
2098
1.71
17.47
2.2
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1240
10002
1.43
17.33
3.6
2.9
ug/l
67.0
68.4
0.13
1176
9479
(44816559) Phosphatidylethanol [Mass/volume] in Blood
122
518
2.39
17.31
1.3
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
655
4672
1.52
17.29
3.8
3.1
estimate
0.0
0.0
0.19
228
1745
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
306
1814
1.75
17.18
4.2
4.5
umol/l
6.3
6.2
0.03
259
1528
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
143
656
2.22
16.94
1.9
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1129
8985
1.43
16.81
5.4
4.2
estimate
0.0
0.0
0.73
234
1801
(3009261) Glucose [Presence] in Urine by Test strip
1134
9041
1.43
16.67
3.9
3.0
estimate
0.0
0.0
0.00
231
1752
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
41
93
4.40
16.48
3.4
3.1
umol/l
197.5
220.8
0.12
21
47
(3052851) Hemolysis interference index of Serum or Plasma
110
458
2.43
16.30
3.4
3.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
192
999
1.97
16.29
9.3
5.9
ng/l
77.5
62.5
1.51
185
951
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
249
1416
1.81
16.07
2.4
2.4
u/l
26.2
67.9
0.66
216
1193
(3007853) Bacteria identified in Skin by Aerobe culture
341
2126
1.67
15.87
1.9
1.6
—
—
—
0
0
(3010421) pH of Blood
87
336
2.61
15.11
5.0
3.9
ph
7.4
7.4
0.10
74
291
(3002385) Erythrocyte distribution width [Ratio]
2027
18138
1.51
14.82
18.5
11.7
%
13.3
13.2
3.03
1996
17753
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1741
15199
1.41
13.97
10.3
6.9
ml/min/173m2
102.6
102.7
0.03
1328
11460
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
290
1795
1.67
13.80
5.6
3.9
ng/l
1316.8
696.8
0.99
227
1399
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
35
83
4.20
13.33
3.0
2.2
umol/l
15.5
17.4
0.40
35
83
(3027945) Reticulocytes/100 erythrocytes in Blood
256
1548
1.70
13.29
4.9
5.2
%
1.5
1.5
0.13
234
1437
(3012516) Albumin [Mass/volume] in Urine
352
2310
1.58
13.20
4.0
3.7
mg/l
105.6
351.0
2.34
265
1688
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
837
6518
1.40
13.19
1.6
1.5
u/ml
2.5
2.1
0.25
190
1553
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
157
821
1.94
13.13
1.4
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
754
5780
1.41
12.99
1.6
1.5
g/l
1.9
1.9
0.19
406
3529
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
532
3826
1.47
12.98
2.9
2.3
ng/l
19.9
107.2
0.61
257
1479
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1771
15588
1.40
12.94
3.7
2.9
mmol/l
2.8
2.8
0.07
1688
14765
(3023511) Choriogonadotropin [Units/volume] in Urine
222
1300
1.75
12.93
1.4
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
54
178
3.03
12.63
4.1
3.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
186
1041
1.82
12.62
3.7
4.2
e9/l
65.5
67.9
0.33
124
686
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
277
1736
1.64
12.53
14.0
7.7
kpa
5.0
5.1
0.11
271
1667
(3026493) Urate [Moles/volume] in Serum or Plasma
405
2774
1.52
12.51
3.1
2.8
umol/l
1044.7
3518.5
1.92
360
2563
(3051651) Icteric interference index of Serum or Plasma
48
149
3.22
12.41
4.1
4.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
358
2392
1.55
12.37
4.7
4.4
mg/mmol
18.3
17.4
0.04
262
1747
(3042517) Benzodiazepines panel - Urine
23
41
5.57
12.18
2.2
2.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
74
295
2.52
12.10
5.3
4.1
mmol/l
2.3
1.9
0.82
40
166
(3007461) Platelets [#/volume] in Blood
2442
23102
2.12
12.04
21.4
13.4
e9/l
266.9
262.8
2.59
2394
22383
(3009343) pH of Capillary blood
274
1731
1.63
11.99
14.2
7.7
ph
7.4
7.4
0.53
15
106
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
271
1716
1.62
11.75
14.2
7.7
mmol/l
0.9
0.9
0.13
181
1251
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1762
15607
1.37
11.58
3.6
2.9
mmol/l
4.5
4.6
3.11
1681
14901
(3000963) Hemoglobin [Mass/volume] in Blood
2444
23155
2.10
11.55
21.6
13.5
g/l
136.1
136.6
1.13
2425
22843
(3035941) MCH [Entitic mass]
2442
23136
2.08
11.43
21.3
13.3
pg
29.6
29.6
1.21
2425
22831
(3026361) Erythrocytes [#/volume] in Blood
2442
23142
2.07
11.32
21.4
13.3
e12/l
4.6
4.6
0.28
2387
22380
(3010813) Leukocytes [#/volume] in Blood
2443
23157
2.07
11.28
21.5
13.4
e9/l
6.9
6.8
2.82
2388
22400
(3044640) Blood type and Crossmatch panel - Blood
672
5152
1.39
11.28
3.1
2.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
331
2218
1.54
11.25
5.1
4.0
s
30.0
30.2
0.13
323
2169
(3024731) MCV [Entitic volume]
2441
23136
2.05
11.20
21.3
13.3
fl
88.3
88.3
0.21
2424
22830
(3036489) Thrombin time
162
902
1.82
11.19
4.7
4.7
s
21.8
22.1
0.32
149
806
(1616796) Gas panel - Central venous blood
75
314
2.40
11.07
4.9
3.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
530
3915
1.42
11.00
2.0
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1742
15458
1.35
10.92
3.5
2.8
mmol/l
1.4
1.4
12.18
1658
14710
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
211
1277
1.69
10.90
4.9
4.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
131
688
1.93
10.85
5.1
5.9
g/l
0.2
0.4
2.33
81
441
(3023183) Ammonium ion [Moles/volume] in Plasma
81
358
2.27
10.59
2.9
3.5
umol/l
32.7
31.9
0.16
75
320
(3042936) Bacteria identified in Isolate by Culture
291
1921
1.56
10.55
2.1
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1673
14799
1.34
10.43
3.3
2.7
mmol/l
1.3
1.2
3.00
1596
14122
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
489
3593
1.42
10.40
2.8
2.5
mg/l
1.7
1.1
0.84
341
2503
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
533
3978
1.41
10.37
3.0
2.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
232
1459
1.62
10.32
15.7
7.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
250
1618
1.58
9.87
1.7
1.6
mu/l
363.5
300.4
1.91
218
1455
(3013512) EKG study
381
2697
1.46
9.87
2.8
2.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
316
2166
1.50
9.60
4.2
2.9
ng/l
443.8
855.3
1.21
172
1132
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
258
1697
1.56
9.49
2.3
1.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
178
1070
1.69
9.44
10.5
10.2
mmol/l
0.1
0.5
0.66
140
816
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
148
846
1.77
9.40
5.1
3.6
mmol/l
1.2
1.2
0.37
132
726
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
80
373
2.15
9.22
3.2
2.8
ug/l
382.4
298.1
0.36
69
331
(3008402) Methanol [Moles/volume] in Serum or Plasma
12
14
8.49
9.19
1.1
2.2
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
12
14
8.49
9.19
1.1
2.4
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
22
49
4.46
9.11
7.8
7.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
82
390
2.11
9.00
1.7
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
348
2467
1.45
8.90
2.8
2.4
u/l
6250.5
6855.9
0.13
108
966
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
158
938
1.70
8.79
2.0
1.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
117
637
1.85
8.73
6.7
3.9
ng/l
141.3
138.7
0.03
105
543
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
146
853
1.73
8.61
6.6
5.4
g/l
3.3
3.2
0.46
140
828
(40768446) Kidney Pathology biopsy report
35
113
3.08
8.57
3.0
2.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
143
841
1.72
8.25
10.1
11.5
inr
1.1
1.1
0.01
18
158
(3000494) Fungus identified in Specimen by Culture
265
1808
1.50
8.22
1.8
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
181
1134
1.62
8.19
3.4
2.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
208
1348
1.57
8.17
4.8
5.2
u/l
240.6
253.7
0.41
195
1292
(3002173) Hemoglobin [Mass/volume] in Arterial blood
143
845
1.71
8.11
9.5
10.8
g/l
123.4
125.9
0.64
137
814
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
29
87
3.31
8.01
9.7
8.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
172
1072
1.62
7.96
10.7
10.1
kpa
13.8
14.6
0.66
167
1025
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
73
349
2.09
7.94
1.6
1.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
172
1073
1.62
7.93
10.7
10.1
kpa
5.2
5.1
0.40
166
1022
(3028626) Oxygen [Partial pressure] in Capillary blood
209
1366
1.55
7.91
16.9
8.2
kpa
9.7
9.7
0.17
202
1319
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
153
927
1.67
7.91
8.1
6.1
%
96.1
93.0
0.92
145
882
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
78
383
2.04
7.91
1.1
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
30
93
3.21
7.87
5.5
4.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
337
2434
1.42
7.76
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
62
281
2.20
7.72
16.4
12.9
u/ml
0.3
0.3
1.72
41
161
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
108
597
1.82
7.72
2.4
1.9
ug/l
4.1
7.5
2.92
99
519
(3009214) Lutropin [Units/volume] in Serum or Plasma
211
1391
1.54
7.69
1.7
1.8
u/l
6.9
7.3
0.22
150
1073
(3016502) Oxygen saturation in Arterial blood
154
944
1.65
7.62
11.5
11.1
%
96.2
96.5
0.19
148
910
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
959
8088
1.27
7.58
4.5
4.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
833
6905
1.28
7.57
2.7
2.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
81
410
1.98
7.56
10.6
7.2
u/ml
351.4
1202.9
—
7
30
(3005719) IgG [Mass/volume] in Serum or Plasma
243
1657
1.49
7.55
3.6
3.0
g/l
9.5
9.9
1.19
234
1537
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
59
267
2.21
7.39
1.9
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
93
499
1.87
7.32
11.2
7.1
iu/ml
415.6
607.8
0.21
14
56
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
183
1184
1.56
7.26
2.6
3.5
pmol/l
5.0
4.8
0.54
168
1078
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
362
2688
1.38
7.07
1.3
1.2
iu/ml
18.5
20.3
0.12
91
755
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
116
673
1.73
7.06
2.3
1.8
u/ml
105.6
93.7
0.53
16
94
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
118
688
1.72
7.06
2.3
1.8
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
22
60
3.64
7.02
8.0
5.7
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
22
60
3.64
7.02
8.1
5.8
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
47
198
2.37
6.97
1.6
1.4
promille
1.1
1.4
0.63
28
145
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
889
7492
1.26
6.91
2.9
2.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
92
502
1.84
6.89
1.7
1.6
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
41
165
2.47
6.72
2.2
1.9
%
91.5
92.1
0.19
41
160
(3019225) pH of Specimen
153
969
1.59
6.66
5.4
3.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
255
1799
1.44
6.66
1.5
1.3
u/ml
365.1
297.9
0.28
231
1679
(3037522) Nuclear Ab [Titer] in Serum
344
2568
1.37
6.48
1.4
1.4
titre
231.4
545.0
9.71
51
454
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
823
6914
1.26
6.47
3.6
2.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
482
3791
1.31
6.39
2.2
2.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
568
4570
1.29
6.35
2.5
2.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
43
183
2.34
6.26
3.0
3.8
umol/l
23.1
25.1
0.98
43
183
(3023323) Follitropin [Units/volume] in Serum or Plasma
223
1557
1.45
6.17
1.7
1.7
iu/l
13.0
15.1
0.63
166
1227
(3017446) Testosterone [Moles/volume] in Serum or Plasma
227
1597
1.44
6.03
2.4
2.1
nmol/l
11.1
11.4
0.17
195
1428
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
332
2495
1.36
5.99
1.3
1.2
u/ml
5.6
9.2
0.64
121
988
(3024928) Oxygen saturation in Venous blood
68
353
1.92
5.98
7.7
10.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
76
415
1.83
5.73
1.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
76
415
1.83
5.73
1.7
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
16
41
3.87
5.59
1.4
1.5
—
—
—
0
0
(3020891) Body temperature
71
383
1.85
5.58
7.5
5.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
218
2928
0.71
5.51
1.2
1.3
—
—
—
0
0
(4146454)
18
51
3.50
5.47
3.9
3.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
26
93
2.77
5.42
5.3
5.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
185
1279
1.46
5.41
1.9
1.8
g/l
1.2
1.2
0.14
177
1198
(3024932) HLA-DR beta [Type]
28
106
2.62
5.25
1.1
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
94
562
1.67
5.21
14.7
14.0
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
102
623
1.64
5.21
3.1
2.5
g/l
65.7
67.0
0.76
97
599
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
64
342
1.87
5.20
1.4
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
28
107
2.60
5.16
1.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
68
373
1.82
5.10
2.9
2.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
563
4637
1.25
5.08
5.9
4.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
226
1646
1.39
4.96
1.2
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
68
377
1.80
4.93
4.4
7.7
mmol/l
23.1
23.7
0.83
63
345
(3016650) Hepatitis A virus Ab [Presence] in Serum
69
387
1.78
4.83
1.1
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
88
529
1.66
4.81
1.4
1.6
titre
59.0
69.8
—
10
60
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
82
487
1.68
4.70
2.0
2.3
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
21
73
2.85
4.64
3.7
2.4
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
37
172
2.14
4.47
1.8
2.1
nmol/l
0.1
0.1
0.32
26
130
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
751
6456
1.21
4.42
2.0
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
248
1870
1.34
4.39
1.2
1.2
iu/ml
192.3
152.2
0.45
69
692
(40761536) Microorganisms panel - Urine sediment
224
1665
1.36
4.36
4.0
3.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
672
5725
1.21
4.32
1.7
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
67
386
1.73
4.31
4.5
4.0
%
55.2
53.6
0.48
67
386
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
31
136
2.26
4.31
2.2
1.5
—
—
—
0
0
(4035726)
136
929
1.47
4.28
1.7
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2051
19339
1.24
4.27
19.1
11.5
g/l
334.2
334.7
1.94
2042
19153
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
44
224
1.95
4.19
1.5
1.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
147
1024
1.44
4.19
1.2
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
130
885
1.47
4.17
2.4
2.4
ml/min/173m2
78.3
87.9
1.26
53
307
(4034850)
70
413
1.69
4.15
9.5
6.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
47
247
1.89
4.09
3.8
5.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
133
918
1.45
3.99
2.0
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
431
5064
0.81
3.99
1.7
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
66
388
1.70
3.98
1.2
1.4
ug/g
345.0
341.9
0.03
29
197
(4010399)
134
927
1.45
3.97
1.4
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
28
122
2.28
3.97
1.5
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
82
511
1.60
3.95
1.4
1.5
—
1704.0
—
0
5
(3014051) Protein [Presence] in Urine by Test strip
63
367
1.71
3.93
2.4
1.8
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
75
458
1.63
3.92
2.0
2.2
g/l
1.3
1.2
0.20
67
411
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
130
2.21
3.86
1.1
1.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
18
64
2.79
3.85
1.3
1.1
u/l
24.7
24.2
0.01
18
56
(3049233) Organic acids panel - Urine
13
38
3.39
3.81
1.3
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
102
675
1.51
3.79
1.6
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
172
1256
1.38
3.77
3.3
2.5
%
29.5
31.8
2.09
134
946
(3006653) Thiamine [Moles/volume] in Blood
18
65
2.74
3.75
1.2
1.4
nmol/l
137.2
143.7
0.30
18
65
(3048689) Calprotectin [Mass/mass] in Stool
431
3557
1.23
3.75
2.6
3.0
ug/g
108.5
114.6
0.14
340
2825
(3045414) Leukocytes [Presence] in Urine
105
702
1.50
3.72
2.0
1.6
—
—
—
0
0
(4024509)
24
101
2.36
3.70
2.5
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
34
166
2.03
3.67
1.3
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
47
257
1.82
3.65
2.6
2.7
%
17.1
17.5
0.23
21
140
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
124
1706
0.70
3.64
1.3
1.3
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
8
12
6.59
3.63
3.0
1.3
nmol/l
29.3
16.5
—
8
12
(3048929) Epstein Barr virus Ab [Presence] in Serum
242
1871
1.30
3.62
1.7
1.5
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
10
25
3.96
3.62
8.1
3.8
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
10
25
3.96
3.62
4.8
10.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
35
174
2.00
3.60
1.1
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
84
539
1.55
3.60
3.2
2.5
e6/l
18.5
20.5
0.07
72
410
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
84
540
1.55
3.58
3.2
2.5
e6/l
183.7
300.5
0.31
73
426
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
127
891
1.43
3.53
2.1
1.6
u/ml
199.8
198.8
0.02
87
488
(3030905) Polymorphonuclear cells [#/volume] in Blood
63
379
1.66
3.52
4.0
3.7
e9/l
3.6
3.8
0.23
63
379
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
18
68
2.62
3.46
1.3
1.1
u/l
88.8
170.5
0.59
18
60
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
26
117
2.20
3.46
1.3
1.1
u/l
142.0
182.0
0.25
21
81
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
62
375
1.65
3.41
1.6
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
54
315
1.71
3.40
4.3
3.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
296
2369
1.26
3.38
1.8
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
38
200
1.89
3.35
3.1
3.0
mmol/l
71.9
82.5
0.73
32
184
(3014765) Yersinia sp identified in Stool by Organism specific culture
90
597
1.50
3.34
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
139
2.07
3.31
1.1
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
141
1021
1.38
3.29
1.6
1.4
—
—
—
0
0
(4062490)
45
252
1.77
3.27
1.3
1.3
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
15
53
2.80
3.27
1.3
3.2
mg/l
40.5
26.9
—
5
24
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
53
312
1.69
3.24
2.6
1.9
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
16
59
2.68
3.23
1.3
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
78
506
1.54
3.22
5.7
5.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
88
589
1.49
3.15
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
184
2326
0.76
3.13
1.5
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
46
263
1.74
3.13
2.5
1.8
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
27
130
2.06
3.07
2.6
1.4
ug/l
17.1
5.3
0.51
27
112
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
59
363
1.62
3.06
1.3
1.4
u/ml
4.2
5.2
0.33
32
177
(3036180) Methadone [Presence] in Urine
6
8
7.41
3.02
1.7
2.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
89
603
1.47
3.01
1.2
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
12
5.76
2.98
8.9
4.5
mmol/l
4.8
6.2
—
7
12
(3044290) Cell count panel - Cerebral spinal fluid
77
509
1.51
2.95
3.3
2.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
47
277
1.69
2.89
4.8
3.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
29
147
1.96
2.88
2.3
1.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
76
504
1.50
2.87
8.5
7.1
mmol/l
24.1
24.1
0.02
70
470
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
43
248
1.72
2.86
3.3
2.8
e6/l
851.6
825.1
—
9
64
(46235355) HIV 1 and 2 tests - Meaningful Use set
947
8542
1.15
2.84
2.6
2.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
267
2157
1.25
2.84
1.8
2.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
910
8201
1.15
2.75
2.0
1.8
—
—
—
0
0
(4306422)
55
343
1.59
2.74
1.2
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
133
986
1.35
2.73
1.6
1.6
mg/l
4.4
3.7
0.55
89
622
(3027135) IgG subclass 1 [Mass/volume] in Serum
43
252
1.69
2.72
1.3
1.3
g/l
5.8
6.0
0.15
34
193
(3024139) IgG subclass 3 [Mass/volume] in Serum
43
252
1.69
2.72
1.3
1.3
g/l
0.3
0.4
0.03
33
192
(3028192) IgG subclass 2 [Mass/volume] in Serum
43
252
1.69
2.72
1.3
1.3
g/l
2.3
2.5
0.53
34
192
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
35
194
1.79
2.68
2.3
2.5
ug/min
111.4
99.2
0.06
23
128
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
18
78
2.28
2.66
1.3
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
68
450
1.50
2.62
2.5
2.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
67
444
1.50
2.57
2.5
2.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
64
421
1.51
2.55
1.4
1.4
u/l
12.6
14.3
0.24
54
375
(3003327) Ova and parasites identified in Stool by Light microscopy
130
974
1.33
2.51
1.7
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
206
1641
1.26
2.50
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
85
595
1.42
2.48
2.7
2.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
155
1194
1.30
2.46
4.6
4.4
%
0.4
0.5
0.24
38
252
(40768441) Liver Pathology biopsy report
25
128
1.93
2.45
1.2
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
29
157
1.83
2.42
1.1
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
165
1285
1.28
2.42
4.8
4.7
%
0.6
0.7
0.48
49
336
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
11
39
2.79
2.41
2.9
3.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
53
339
1.55
2.41
4.7
3.0
e9/l
1.3
1.4
0.25
39
205
(40757494) Bilirubin.total [Moles/volume] in Blood
20
95
2.08
2.40
3.5
3.5
umol/l
94.5
110.6
—
8
37
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
12
4.94
2.37
2.0
2.5
ng/l
54.7
112.6
—
6
12
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
47
294
1.59
2.35
4.8
2.9
%
8.5
10.3
0.71
38
230
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
9
27
3.29
2.35
1.1
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
7
17
4.07
2.33
1.0
1.0
ng/l
26.5
34.3
—
7
10
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
7
17
4.07
2.33
1.0
1.0
ng/l
213.8
247.0
—
7
11
(3034274) Bile acid [Moles/volume] in Serum --fasting
102
746
1.36
2.32
2.9
3.1
umol/l
8.0
7.5
0.09
80
594
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
47
295
1.58
2.32
2.5
1.8
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
47
297
1.57
2.27
4.8
2.9
%
67.6
70.1
0.28
47
290
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
25
132
1.88
2.26
1.4
1.3
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
47
298
1.57
2.24
4.7
3.0
e9/l
0.2
0.2
0.26
41
226
(3049717) Cytology report of Urine Cyto stain
30
169
1.76
2.22
1.5
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
98
719
1.36
2.21
1.4
1.3
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
31
177
1.74
2.20
1.5
1.6
u/ml
0.5
12.1
2.14
11
44
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
31
177
1.74
2.20
1.3
1.5
pmol/l
254.3
444.2
1.56
23
140
(3024980) IgG subclass 4 [Mass/volume] in Serum
57
379
1.49
2.20
1.4
1.7
g/l
0.6
0.7
0.72
46
306
(3029396) Erythrocyte agglutination [Presence] in Blood
27
148
1.81
2.19
3.6
3.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
19
92
2.04
2.19
3.9
2.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
9
5.49
2.19
1.2
1.2
umol/l
28.0
28.0
—
5
9
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
24
127
1.87
2.17
1.3
1.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
47
302
1.54
2.13
4.7
3.0
e6/l
559.5
548.2
0.06
41
225
(1761868) Lipid panel - Serum or Plasma
588
6410
0.88
2.13
2.3
2.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
60
407
1.46
2.11
1.7
2.5
nmol/l
0.9
0.6
0.66
49
357
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
57
383
1.48
2.10
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2138
20547
1.16
2.10
17.0
10.5
%
40.3
40.4
0.44
1796
17749
(3020876) Protein [Mass/time] in 24 hour Urine
14
61
2.27
2.08
2.4
1.9
—
2.6
—
0
11
(44790049)
47
304
1.53
2.07
2.4
1.9
—
—
—
0
0
(44790048)
47
304
1.53
2.07
2.4
1.9
—
—
—
0
0
(44790047)
47
304
1.53
2.07
2.4
1.9
—
—
—
0
0
(44806118)
47
304
1.53
2.07
2.4
1.9
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
7
20
3.46
2.02
1.6
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
104
1329
0.76
2.00
1.4
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
39
244
1.58
1.99
1.9
1.8
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
55
372
1.47
1.98
1.3
1.4
u/ml
2.8
4.9
0.56
24
150
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
10
38
2.60
1.95
1.1
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
53
357
1.47
1.95
2.5
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
35
215
1.61
1.93
8.4
4.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
177
1.68
1.93
1.5
1.6
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
31
185
1.66
1.91
1.6
1.7
mu/l
85.4
125.3
0.26
25
165
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
22
119
1.83
1.89
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
32
194
1.63
1.87
1.8
1.7
—
—
—
0
0
(1002224) Polysomnography panel
95
715
1.32
1.85
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
26
150
1.72
1.82
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
27
158
1.69
1.80
1.1
1.2
nmol/l
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
28
166
1.67
1.79
1.1
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
26
151
1.70
1.78
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
39
252
1.53
1.77
1.1
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
66
2.10
1.76
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
153
1234
1.24
1.74
4.9
4.8
%
0.0
0.1
1.85
45
314
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
25
145
1.71
1.73
3.5
2.5
umol/l
55.4
54.4
0.08
20
130
(3002619) Bacteria identified in Specimen by Culture
11
47
2.31
1.72
1.1
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
11
47
2.31
1.72
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
36
230
1.55
1.72
1.1
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
41
2.41
1.70
1.8
2.2
—
—
—
0
0
(3032641) Amino acids panel - Urine
8
30
2.63
1.69
1.3
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
17
88
1.91
1.68
1.0
1.1
—
—
—
0
0
(44813793)
38
248
1.52
1.66
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
230
1943
1.18
1.64
1.1
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
25
2.77
1.62
1.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
134
1075
1.24
1.62
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
42
282
1.48
1.62
3.0
2.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
35
226
1.53
1.61
1.1
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
147
1192
1.23
1.61
4.9
4.8
%
0.0
0.1
1.69
39
273
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
13
62
2.07
1.60
1.1
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
5
14
3.53
1.59
1.6
1.8
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
38
251
1.50
1.59
1.1
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
11
49
2.22
1.58
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
22
127
1.71
1.57
2.5
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
28
173
1.60
1.56
1.6
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
13
63
2.04
1.54
1.4
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
88
676
1.29
1.53
1.2
1.2
u/ml
0.2
0.6
—
5
43
(3022621) pH of Urine by Test strip
128
1030
1.24
1.52
2.6
2.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
177
1472
1.20
1.52
1.4
1.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
11
50
2.17
1.52
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
89
687
1.29
1.50
1.5
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
174
1447
1.20
1.50
1.3
1.3
miu/ml
188.9
239.9
1.20
69
729
(21494434) Karyotype in Bone marrow
20
114
1.74
1.50
1.5
1.3
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
37
248
1.48
1.46
1.1
1.2
u/ml
2.1
18.5
0.95
29
186
(3000060) B lymphocytes [#/volume] in Blood
36
240
1.49
1.46
5.4
3.0
e6/l
290.7
347.4
0.40
30
148
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
56
406
1.37
1.45
1.4
1.1
iu/ml
102.0
165.8
0.33
21
139
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
9
38
2.34
1.44
1.1
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
9
38
2.34
1.44
2.4
2.8
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
65
1.98
1.43
1.4
1.4
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
13
65
1.98
1.43
2.0
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
34
225
1.50
1.43
1.2
1.3
—
128.6
—
0
7
(4268621)
39
266
1.45
1.42
2.3
2.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
26
162
1.59
1.42
1.7
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
440
3939
1.12
1.41
1.5
1.5
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
36
242
1.47
1.41
1.3
1.1
mg/l
35.1
38.4
0.19
30
190
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
30
194
1.53
1.40
1.1
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
31
202
1.52
1.40
10.1
15.5
%
10.7
11.6
0.68
31
202
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
19
109
1.72
1.40
1.5
1.1
%
80.1
88.9
—
8
52
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
11
52
2.09
1.39
1.1
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
66
1.95
1.38
4.1
5.8
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
27
172
1.55
1.35
1.8
1.4
u/ml
0.9
0.6
—
7
45
(3045788) Cell count panel - Pleural fluid
9
41
2.17
1.35
1.1
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
41
2.17
1.35
1.1
1.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
13
67
1.92
1.33
1.1
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
19
111
1.69
1.33
2.1
3.2
u/ml
832.7
779.2
0.08
19
111
(3025130) Human papilloma virus identified in Specimen
46
329
1.39
1.31
1.9
1.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
16
89
1.78
1.31
1.6
2.0
—
—
—
0
0
(4027681)
31
206
1.49
1.30
1.4
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
47
2.10
1.29
2.0
1.8
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
24
2.47
1.28
1.0
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
77
599
1.28
1.26
1.5
1.6
nmol/l
0.3
0.4
0.98
60
502
(3025468) Yersinia sp identified in Specimen by Organism specific culture
28
184
1.51
1.24
1.6
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
35
241
1.44
1.24
2.0
2.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
38
266
1.41
1.24
1.4
1.6
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
12
62
1.91
1.23
4.5
10.4
mmol/l
1.2
1.2
0.12
12
56
(3028679) Herpes simplex virus Ab [Presence] in Serum
29
193
1.49
1.22
1.1
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
28
185
1.50
1.22
1.6
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
28
185
1.50
1.22
1.6
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
28
185
1.50
1.22
1.6
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
790
7341
1.09
1.20
1.7
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
112
915
1.22
1.20
1.2
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
636
5854
1.10
1.20
2.0
1.8
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
8
37
2.14
1.19
1.4
1.5
u/l
9.3
14.2
—
8
37
(3008757) Leukocyte morphology finding [Identifier] in Blood
34
235
1.43
1.19
4.1
3.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
27
389
0.68
1.19
1.7
1.5
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
19
115
1.63
1.19
1.4
1.1
%
89.5
94.8
—
8
56
(40761995) Spermatozoa Progressive [#/volume] in Semen
9
168
0.53
1.18
2.6
2.8
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
9
168
0.53
1.18
5.1
5.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
10
49
2.02
1.18
1.7
1.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
14
78
1.77
1.16
1.8
1.5
u/l
2.2
2.2
—
9
41
(3020874) Milk IgE Ab [Units/volume] in Serum
51
381
1.33
1.14
1.3
1.3
u/ml
0.7
4.5
3.35
26
201
(3012441) Differential panel - Pleural fluid
10
50
1.98
1.12
1.3
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
20
125
1.58
1.12
1.1
1.3
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
79
628
1.25
1.11
1.1
1.1
u/ml
0.3
0.5
0.28
26
210
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
24
157
1.51
1.11
1.0
1.0
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
30
206
1.44
1.10
1.1
1.3
u/ml
22.7
12.0
0.27
23
163
(3042631) Mycobacterium sp identified in Specimen
14
80
1.73
1.08
8.6
2.9
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
17
103
1.63
1.07
1.1
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
146
1238
1.17
1.07
1.4
1.5
—
—
—
0
0
(3022670) pH of Venous cord blood
10
51
1.94
1.07
1.0
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
10
51
1.94
1.07
1.6
2.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
28
191
1.45
1.07
1.6
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
31
216
1.42
1.06
1.5
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
19
119
1.58
1.06
3.1
2.5
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
35
469
0.73
1.05
1.9
1.7
mmol/l
7.0
7.2
0.12
16
288
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
117
1358
0.84
1.05
1.5
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
141
1195
1.17
1.05
2.0
2.1
e9/l
4.1
4.2
0.16
107
1045
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
67
1.77
1.00
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
27
186
1.44
0.99
1.7
1.5
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
11
60
1.81
0.99
2.5
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
52
652
0.78
0.98
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
52
651
0.78
0.97
1.2
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
10
53
1.86
0.97
2.0
1.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
18
114
1.56
0.97
7.2
6.2
mg/l
91.0
80.8
0.28
18
102
(3017354) Segmented neutrophils/100 leukocytes in Blood
19
122
1.54
0.97
3.8
3.3
%
62.2
51.6
1.01
11
77
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
9
49
1.81
0.97
1.3
1.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
49
1.81
0.97
1.6
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
49
1.81
0.97
2.1
1.8
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
49
1.81
0.97
1.3
1.6
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
49
1.81
0.97
1.6
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
68
1.74
0.96
1.1
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
25
171
1.45
0.96
1.2
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
15
91
1.63
0.96
2.7
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
36
1.92
0.95
2.1
2.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
36
1.92
0.95
2.1
2.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
45
341
1.31
0.95
5.7
5.7
mmol/l
1.2
1.2
0.12
39
296
(3005033) Fetal Nuchal fold Thickness US
141
1207
1.16
0.94
1.4
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
44
333
1.31
0.94
1.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
141
1208
1.16
0.94
1.4
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
72
580
1.23
0.93
1.1
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
14
84
1.65
0.93
1.4
1.2
%
95.7
108.2
0.72
14
74
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
14
84
1.65
0.93
1.0
1.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
10
54
1.83
0.93
5.0
9.7
mmol/l
1.2
1.2
—
10
47
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
54
1.83
0.93
2.0
1.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
10
54
1.83
0.93
2.8
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
129
1467
0.86
0.92
1.7
1.8
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
37
1.87
0.92
1.6
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
113
1298
0.85
0.92
2.1
2.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
42
317
1.31
0.92
1.1
1.1
u/ml
0.4
2.1
—
9
76
(3004809) Band form neutrophils/100 leukocytes in Blood
31
223
1.38
0.92
4.8
3.4
%
1.0
1.0
0.01
22
178
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
70
564
1.23
0.91
1.3
2.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
72
860
0.82
0.90
1.0
1.1
u/ml
1.2
6.4
—
7
121
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
137
1175
1.16
0.90
1.3
1.2
—
37.4
—
0
36
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
26
182
1.41
0.90
1.0
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
63
503
1.24
0.90
1.7
2.0
iu/l
5.8
4.4
0.27
22
204
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
15
93
1.59
0.89
1.3
1.2
g/l
0.3
0.3
—
9
77
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
12
70
1.69
0.88
1.5
1.7
nmol/l
17.0
18.6
—
6
21
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
8
43
1.84
0.86
1.3
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
15
94
1.58
0.86
2.3
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
15
94
1.58
0.86
2.3
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
15
94
1.58
0.86
2.3
1.9
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
23
159
1.43
0.85
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
26
184
1.40
0.85
1.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
22
151
1.44
0.85
1.7
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
41
517
0.78
0.84
1.0
1.1
u/ml
2.4
3.3
—
9
231
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
188
1658
1.13
0.84
2.7
2.6
ug/l
1.3
1.3
0.06
173
1536
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
29
210
1.37
0.84
1.6
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
16
103
1.53
0.83
1.0
1.2
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
11
64
1.70
0.82
1.0
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
86
717
1.19
0.82
1.1
1.1
u/ml
10.3
8.1
0.29
40
381
(3001186) Copper [Moles/volume] in Serum or Plasma
12
72
1.65
0.81
1.2
1.5
umol/l
17.2
17.5
0.06
12
67
(3014133) Dog dander IgE Ab [Units/volume] in Serum
93
783
1.18
0.80
1.1
1.1
u/ml
3.6
5.8
0.88
42
390
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
47
1.68
0.79
1.0
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
10
161
0.61
0.79
1.2
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
25
179
1.38
0.78
2.1
1.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
105
1.51
0.77
1.7
1.8
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
2.2
—
2.6
—
0
12
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
54
433
1.23
0.77
1.5
1.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
40
310
1.28
0.75
4.5
4.4
u/ml
23.3
14.4
0.19
40
267
(3014148) Varicella zoster virus Ab [Titer] in Serum
67
551
1.20
0.75
1.1
1.2
—
—
—
0
0
(3000492) Spirometry study
207
1851
1.11
0.75
1.4
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
107
918
1.16
0.74
1.4
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
25
182
1.36
0.72
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
25
182
1.36
0.72
1.1
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
25
1.97
0.72
1.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
16
107
1.48
0.72
2.6
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
91
1.52
0.71
1.9
1.7
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
18
124
1.43
0.70
2.8
2.9
ug/l
43.2
215.8
0.43
18
110
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
25
183
1.35
0.70
1.1
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
44
349
1.25
0.70
2.0
2.5
g/l
131.8
134.9
0.42
38
283
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
108
934
1.15
0.68
1.4
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
58
1.53
0.68
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
142
1251
1.13
0.68
1.3
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
26
193
1.33
0.68
1.3
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
5
27
1.83
0.67
1.6
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
27
1.83
0.67
1.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
14
93
1.49
0.65
1.3
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
30
229
1.30
0.65
1.9
1.8
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
26
332
0.77
0.63
1.5
1.6
mmol/l
6.4
6.6
0.12
18
231
(3004716) Salmonella sp identified in Stool by Organism specific culture
207
1872
1.10
0.63
1.3
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
8
48
1.65
0.62
1.3
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
49
1.61
0.61
3.3
2.7
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
15
103
1.44
0.61
1.9
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
30
1.64
0.60
1.2
1.9
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
14
95
1.46
0.60
3.0
2.7
u/field
4.6
1.5
—
8
57
(3006598) pH of Arterial cord blood
28
215
1.29
0.60
1.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
28
215
1.29
0.60
1.0
1.0
kpa
7.0
7.3
0.26
19
184
(3041096) Erythrocytes [Presence] in Urine by Automated
563
5302
1.06
0.60
3.0
2.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
10
63
1.57
0.58
1.5
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
7
113
0.61
0.58
1.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
26
327
0.78
0.58
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
24
182
1.30
0.56
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
24
182
1.30
0.56
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
24
182
1.30
0.56
1.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
24
182
1.30
0.56
1.3
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
15
105
1.41
0.56
1.3
1.7
%
52.1
48.7
—
10
81
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
64
543
1.17
0.55
2.3
2.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
14
97
1.43
0.55
1.2
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
37
1.60
0.55
1.2
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
169
1531
1.09
0.52
1.4
1.5
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
6
95
0.62
0.52
1.2
1.3
—
36.2
—
0
11
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
169
1532
1.09
0.52
1.4
1.5
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
45
373
1.19
0.51
1.2
1.3
u/ml
7.3
14.3
0.40
22
183
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
168
1523
1.09
0.51
1.4
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
24
185
1.28
0.51
1.1
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
116
1.36
0.50
1.3
1.2
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
27
212
1.26
0.50
1.0
1.0
kpa
3.6
3.3
0.18
18
181
(21494814) CD8 cells/100 lymphocytes in Specimen
10
66
1.50
0.49
3.0
2.6
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
12
83
1.43
0.48
1.3
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
12
83
1.43
0.48
1.3
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
12
83
1.43
0.48
1.3
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
46
1.50
0.48
1.0
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
168
1531
1.09
0.47
1.4
1.4
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
27
215
1.24
0.46
1.0
1.0
mmol/l
-3.6
-2.4
—
6
43
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
12
84
1.41
0.46
1.0
1.1
u/ml
0.1
3.9
2.18
12
65
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
12
84
1.41
0.46
1.0
1.1
u/ml
0.3
0.5
—
5
53
(40768443) Skin Pathology biopsy report
62
535
1.15
0.46
1.2
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
18
136
1.31
0.45
1.1
1.1
u/l
1.0
1.0
—
10
61
(3003888) Timothy IgE Ab [Units/volume] in Serum
119
1071
1.10
0.44
1.1
1.1
u/ml
6.2
7.3
0.29
69
706
(3001964) Herpes simplex virus Ag [Presence] in Specimen
12
85
1.39
0.44
2.0
2.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
18
137
1.30
0.43
1.3
1.2
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
15
111
1.33
0.43
1.7
1.2
—
66.1
—
0
14
(3000093) Morphology [Interpretation] in Blood Narrative
21
164
1.26
0.42
1.5
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
6
92
0.64
0.42
1.2
1.3
—
37.6
—
0
8
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
200
1.23
0.42
1.5
1.6
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
6
94
0.63
0.42
1.2
1.3
—
58.6
—
0
12
(44806071)
5
32
1.54
0.42
1.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
57
1.39
0.41
3.6
5.5
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
8
57
1.39
0.41
1.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
93
831
1.11
0.41
1.5
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
58
1.36
0.41
3.6
5.7
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
5
33
1.49
0.41
1.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
33
1.49
0.41
1.2
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
144
1530
0.92
0.40
1.5
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
100
0.69
0.39
1.1
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
211
1.22
0.39
1.4
1.5
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
5
35
1.41
0.38
1.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
66
1.35
0.38
2.7
3.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
36
1.37
0.37
1.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
32
267
1.18
0.37
1.2
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
69
1.29
0.36
4.4
1.4
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
13
97
1.32
0.36
1.0
1.1
u/ml
1.1
5.0
—
5
52
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
38
323
1.16
0.36
1.7
2.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
79
0.62
0.35
10.0
8.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
20
160
1.23
0.35
1.5
1.7
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
114
1040
1.08
0.35
1.1
1.1
u/ml
2.1
1.3
0.37
62
604
(40768806) Pleura Pathology biopsy report
6
43
1.38
0.34
1.2
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
43
1.38
0.34
1.0
1.5
ug/l
13.5
8.7
—
6
43
(3016273) Islet cell 512 Ab [Units/volume] in Serum
10
72
1.37
0.34
1.3
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
23
271
0.84
0.33
1.2
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
89
0.66
0.32
1.2
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
46
1.29
0.32
3.3
2.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
46
1.29
0.32
3.3
2.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
10
73
1.35
0.32
2.0
1.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
28
235
1.18
0.32
1.2
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
181
1689
1.06
0.31
1.4
1.5
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
7
52
1.33
0.31
1.3
2.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
52
1.33
0.31
1.1
1.1
—
—
—
0
0
(4133840)
7
53
1.30
0.30
1.1
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
88
936
0.92
0.28
2.0
2.0
ug/l
0.5
0.6
1.33
51
397
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
75
1.32
0.28
1.1
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
63
1.25
0.27
3.4
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
63
1.25
0.27
3.4
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
63
1.25
0.27
3.4
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
63
1.25
0.27
3.4
2.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
89
816
1.08
0.26
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
33
287
1.14
0.26
1.1
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
42
372
1.12
0.25
2.9
2.8
mg/l
20.7
24.7
0.39
25
225
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
30
335
0.88
0.24
1.1
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
23
196
1.16
0.23
1.1
1.9
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
25
215
1.15
0.23
1.9
1.6
e6/l
8168.7
10198.8
0.27
18
155
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
127
1187
1.06
0.23
1.2
1.2
u/ml
0.6
2.5
5.73
62
664
(3024263) Appearance of Synovial fluid
5
38
1.30
0.23
3.6
2.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
91
0.76
0.22
1.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
41
1.20
0.21
1.2
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
5
41
1.20
0.21
3.6
2.3
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
10
0.00
0.21
0.0
1.4
—
986.2
—
0
10
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
10
0.00
0.21
0.0
3.6
—
1999.2
—
0
10
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025296) Carrot IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.1
—
0
5
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.3
—
0
5
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
6
47
1.26
0.20
1.2
1.2
—
62.2
—
0
9
(3044941) Cell count panel - Synovial fluid
13
153
0.84
0.20
1.8
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
32
350
0.90
0.20
1.2
1.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
9
113
0.78
0.20
1.2
1.5
%
—
78.1
—
0
14
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
49
1.21
0.20
3.3
2.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
54
495
1.08
0.18
2.2
1.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
203
2067
0.97
0.17
1.4
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
31
278
1.10
0.16
1.7
1.5
mmol/l
13.2
11.0
—
6
43
(3040151) Glucose [Moles/volume] in Capillary blood
22
193
1.12
0.16
2.0
6.3
mmol/l
5.6
6.3
0.98
15
157
(3010726) Horse dander IgE Ab [Units/volume] in Serum
112
1057
1.05
0.16
1.1
1.1
u/ml
4.1
3.4
0.19
36
338
(3047007) Chlamydophila sp Ab [Presence] in Serum
49
517
0.93
0.15
1.2
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
314
3168
0.97
0.15
1.5
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
9
77
1.15
0.15
2.7
2.2
—
—
—
0
0
(4281824)
9
81
1.10
0.15
1.2
1.1
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
29
312
0.92
0.14
1.1
1.1
iu/ml
2.0
6.6
—
7
63
(3023419) Bacteria identified in Sputum by Culture
12
101
1.17
0.14
9.3
5.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
30
321
0.92
0.13
1.2
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
10
83
1.19
0.13
1.0
1.1
iu/ml
—
5.1
—
0
10
(3029075) Extractable nuclear Ab panel - Serum
9
104
0.85
0.13
1.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
20
218
0.90
0.13
3.9
2.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
17
187
0.90
0.12
1.4
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
26
278
0.92
0.12
2.3
2.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
12
135
0.88
0.12
1.3
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
29
266
1.08
0.10
1.4
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
26
238
1.08
0.10
1.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
46
1.07
0.09
1.4
3.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
47
1.05
0.09
2.6
1.9
—
—
—
0
0
(3000012) Reticulocyte production index
6
54
1.10
0.09
1.2
1.5
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
6
54
1.10
0.09
1.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
17
153
1.10
0.09
1.3
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
17
153
1.10
0.09
1.0
1.1
miu/ml
1771.1
1472.0
0.42
17
153
(3045683) HLA typing for celiac disease panel - Blood or Tissue
23
211
1.08
0.08
1.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
58
1.02
0.08
1.5
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
56
531
1.04
0.08
2.8
4.0
ug/l
2.7
5.9
2.12
40
366
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
85
863
0.97
0.08
1.3
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
78
793
0.97
0.08
1.8
1.9
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
7
66
1.05
0.08
1.1
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
68
649
1.03
0.07
1.7
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
85
1.04
0.07
1.1
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
86
1.03
0.07
1.4
1.3
—
—
—
0
0
(4211845)
9
87
1.02
0.07
2.7
2.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
17
155
1.08
0.06
1.2
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
89
0.89
0.06
1.5
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
8
92
0.86
0.06
1.5
2.1
mmol/l
4.0
3.9
—
8
92
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
107
1.11
0.06
2.6
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
11
120
0.90
0.06
1.2
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2043
20105
1.01
0.06
4.2
3.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
12
108
1.10
0.05
1.7
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
76
732
1.02
0.05
1.6
1.6
iu/ml
0.0
0.1
0.91
17
148
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
131
1272
1.02
0.05
2.9
2.6
%
19.1
22.9
1.44
36
325
(3018738) Hemoglobin F/Hemoglobin.total in Blood
12
109
1.09
0.04
4.0
4.0
%
0.2
3.7
—
6
43
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
25
238
1.04
0.02
1.4
2.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
16
150
1.05
0.02
1.0
1.2
ratio
1.1
1.1
—
7
67
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
49
492
0.98
0.02
1.2
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
10
92
1.07
0.01
1.4
2.2
—
556.6
—
0
7
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
21
200
1.04
0.01
1.1
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
13
122
1.05
0.01
2.4
3.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
13
122
1.05
0.01
2.4
3.7
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
22
214
1.01
0.00
1.1
1.4
—
155.0
—
0
12
(42870560) Thyrotropin [Units/volume] in Cord blood
28
275
1.00
0.00
1.0
1.0
mu/l
8.8
8.8
0.01
21
238
(3021788) Differential panel - Synovial fluid
18
181
0.98
0.00
1.3
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
30
301
0.98
0.00
1.2
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
11
105
1.03
0.00
1.0
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
25
243
1.01
0.00
1.1
1.3
—
41.4
—
0
13
(4094501)
21
207
1.00
0.00
1.2
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
53
522
1.00
0.00
1.1
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
12
123
0.96
0.00
1.0
1.1
iu/ml
192.7
209.8
0.08
12
123
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
87
0.91
0.00
1.5
2.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
60
0.99
0.00
17.0
5.3
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3034426) Prothrombin time (PT)
9
91
0.98
0.00
1.1
1.4
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
53
0.93
0.00
1.2
1.2
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
7
72
0.96
0.00
1.1
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
1.5
—
0
5
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
63
0.94
0.00
1.0
1.2
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
213.0
—
0
6
(36303858) Crystals [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017497) Pine Nut IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
0.0
—
0
6
(3015350) Toxocara sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
66
0.90
0.00
1.5
1.4
u/l
166.3
189.7
—
6
66
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
9
90
0.99
0.00
1.4
2.2
mmol/l
107.9
106.0
—
9
90
(3000285) Sodium [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
73
0.95
0.00
1.1
1.1
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
4.4
—
0.3
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: F5_BEHEMOTH – Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).